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Cardiovascular disease is the leading cause of death in firefighters (FF) around the
nation. Recent observational studies have emerged suggesting that FF consume
calorically dense foods, high in sugar and fat, but low in nutritional value which can
exacerbate heart diseases and impair performance. The potential to improve
cardiometabolic and performance measurements when following a carbohydrate (CHO)
restricted diet (CRD) has gained interest in the literature. To date, only one study has
employed a nutrition intervention in FF, yet its’ focus was on nutrient dense foods and
antioxidant supplements. Therefore, the purpose of this study was to examine the
cardiometabolic and performance effects of a 28-day CRD in FF. 15 career FF
participated and finished the present study. Participants reported to the laboratory on 9
separate occasions. Trial 1 consisted of participants having a blood draw performed for
assessment of their heart disease risk followed by body composition, blood pressure, and
a glucose challenge test (GCT) to assess glucose impairment following ingestion of a 75
g glucose beverage. Trial 2 consisted of a graded exercise cycling test with 5 stages
followed by a maximal Wingate for 30 s. Finally, the last trial included the FF physical

performance assessment (FPPA) which consisted of a 2.41-km run followed by 2 min of
maximal pull-ups, push-ups, and sit-ups. The first 3 trials were used as familiarizations,
the second 3 trials were used as baseline measurements, and the last 3 trials followed the
28-day CRD. The CRD consisted of ad-libitum consumption of fat and protein and
keeping CHO < 25% daily kilocalorie intake. Dependent variables measured pre- and
post-diet included body composition, lipid profile, insulin, cortisol, c-reactive protein
(CRP), GCT, substrate oxidation rates, Wingate variables, and the FPPA. Following the
diet, participants had significant reductions in CRP, blood pressure, 2.41-km run time,
CHO oxidation rates, and fat mass. Participants also had significant increases in high
density cholesterol count, fat oxidation rates, and pull-up repetitions. Overall, our results
show that a CRD in a high-stress occupation can favorably change markers of heart
disease and body composition without decrements to physical performance.

DEDICATION
This dissertation is dedicated to the four women in my life who have provided
support throughout my academic journey. My grandmother, Patricia Thomas, who “left
me alone” for my academic studies and has always reminded me of how proud she is. My
mother, Shannon Bumgardner, who has been my biggest role model and greatest source
of inspiration. My sister, Hayley Waldman, who has kept me grounded, humbled, and
never stopped encouraging her big brother. Finally, to my wife, Erica Waldman. You
have sacrificed so much to see me bring this journey to an end and yet, you have never
once complained or asked me to stop. Many times I came home disappointed and
defeated, but you always encouraged me to keep going. This degree is as much yours as it
is mine. I am thankful God placed you in my life and that we may now pursue other
aspirations together.

iv

ACKNOWLEDGEMENTS
I would like to acknowledge and thank my committee members (Drs. Matthew
McAllister, JohnEric Smith, Brent Fountain, and John Lamberth) for their guidance and
feedback to this dissertation and all previous projects. Dr. Matthew McAllister, thank you
for instilling in me the want to become a producer of knowledge rather than just a
consumer. Thank you for teaching me to see things for what they could be and not for
what they are. I have always strived to match your drive, dedication, and knowledge in
our field. I will forever be proud to say I was your first doctoral student. Dr. JohnEric
Smith, thank you for reminding me to not always be such a scientist and reminding me
not to lose sight of the forest for the trees. Dr. Brent Fountain, thank you for your
knowledge and guidance on all of our projects we have collaborated on. Your knowledge
of nutrition is humbling and where I strive to be one day. Dr. John Lamberth, thank you
for our afternoon talks about your farm, school politics, and Navy life. You always
reminded me there is more to this life than merely school. I also want to acknowledge Dr.
Eric O’Neal and Dr. Benjamin Krings. Dr. O’ was my first academic mentor and
unknowingly kept me from dropping out of school as an undergraduate with his course:
HPE 225, Human Performance and Nutrition. It was this course that I found my love for
exercise science and nutrition. Dr. Benjamin Krings was my office mate and doctoral
colleague during our Ph.D. years together. Dr. Krings and I maintained a healthy
competition as friends, students, and researchers which has played a significant role in
v

my success today. Finally, thank you to all the other undergraduates, graduates, and
faculty members who have assisted with this project as it would not have been possible
without your help.

vi

TABLE OF CONTENTS
DEDICATION ................................................................................................................... iv
ACKNOWLEDGEMENTS ................................................................................................ v
TABLE OF CONTENTS .................................................................................................. vii
LIST OF TABLES .............................................................................................................. x
LIST OF FIGURES ........................................................................................................... xi
I.

INTRODUCTION ................................................................................................1

II.

LITERATURE REVIEW .....................................................................................6
An Introduction to Cardiovascular Disease ...........................................................6
Cardiovascular Disease and Nutrition .............................................................6
Origin of the Current Dietary Guidelines ........................................................8
Problems in the Current Research Paradigm. ............................................9
Calories In vs. Calories Out.................................................................9
An Overview of Dietary Lipids ...........................................................................11
Classification/Structure .................................................................................11
Organization of Triacylglycerols ...................................................................12
Digestion........................................................................................................13
Absorption .....................................................................................................14
Transportation................................................................................................15
Storage ...........................................................................................................15
Metabolism ....................................................................................................16
Macronutrient Manipulation ................................................................................18
Characteristics of a Carbohydrate Restricted Diet ........................................19
Metabolic Flexibility .....................................................................................20
Cardiometabolic Responses to Carbohydrate Restriction ...................................22
Insulin Responses ..........................................................................................23
Cortisol Responses ........................................................................................24
Cholesterol & Lipids .....................................................................................27
Glucose ..........................................................................................................31
C-Reactive Protein.........................................................................................32
Body Composition .........................................................................................34
Firefighter Performance.................................................................................36
vii

III.

MATERIALS AND METHODS ........................................................................39
Participants ..........................................................................................................39
Selection Criteria ...........................................................................................39
Experimental Design ...........................................................................................40
Experimental Procedures .....................................................................................41
Trials 1, 4, and 7 ............................................................................................41
Blood Sampling and Glucose Challenge Test .........................................41
Insulin ...............................................................................................43
Cortisol. .............................................................................................44
C-Reactive Protein.............................................................................44
Lipid Panel.........................................................................................45
Trials 2, 5, and 8 ............................................................................................45
Graded Exercise and Wingate Testing ....................................................45
Substrate Metabolism Calculations .........................................................46
Trials 3, 6, and 9 ............................................................................................47
Firefighter Physical Performance Assessment ........................................47
Dietary Manipulation...............................................................................47
Physical Fitness Regimen ........................................................................49
Statistical Methods ..............................................................................................50

IV.

RESULTS ...........................................................................................................53
Anthropometrics ..................................................................................................53
Blood Concentrations ..........................................................................................54
Wingate Testing...................................................................................................55
Mean Power Output .......................................................................................55
Peak Power Output ........................................................................................55
Fatigue Index .................................................................................................55
Total Work.....................................................................................................55
Wingate Heart Rate .......................................................................................55
Firefighter Physical Performance Assessment ....................................................56
Glucose Challenge Test .......................................................................................56
Graded Exercise Testing......................................................................................57
Substrate Oxidation Rates .............................................................................57
Cardiorespiratory Responses .........................................................................57
Macronutrient Diet Breakdown ...........................................................................60
Kilocalories and Nutrients .............................................................................60
Dietary Carbohydrate Intake .........................................................................60
Dietary Protein Intake....................................................................................61
Dietary Fat Intake ..........................................................................................61

V.

DISCUSSION .....................................................................................................71

VI.

CONCLUSION ...................................................................................................84
viii

REFERENCES ................................................................................................................. 85
APPENDIX
A.

IRB APPROVAL ..............................................................................................124

B.

INFORMED CONSENT ..................................................................................126

ix

LIST OF TABLES
1.

Body Composition and Lipid Responses .........................................................68

2.

Wingate Testing ...............................................................................................69

3.

Macronutrient Composition Breakdown..........................................................70

x

LIST OF FIGURES
1.

Schematic of experimental protocol. ...............................................................52

2.

Insulin. .............................................................................................................62

3.

Cortisol.............................................................................................................63

4.

C-Reactive Protein. ..........................................................................................64

5.

Firefighter physical performance assessment. .................................................65

6.

Glucose challenge test......................................................................................66

7.

Substrate oxidation rates. .................................................................................67

xi

CHAPTER I
INTRODUCTION
Firefighters (FF) exhibit some of the highest rates of obesity and cardiovascular
disease (CVD) in North America (Dobson et al., 2013; Gordon & Larivière, 2014;
Huang, Webb, Zourdos, & Acevedo, 2013). FF are also exposed to a variety of stressors
such as disturbed sleep patterns, frequent snacking of calorically dense foods, smoke
exposure, intense physical exertion, all of which can exacerbate the progression of CVD
and lead to possible sudden cardiac death (Soteriades, Smith, Tsismenakis, Baur, &
Kales, 2011; Superko et al., 2011). Further, FF express a spectrum of risk factors for the
development of CVD collectively known as Syndrome X or metabolic syndrome. The
components which make up metabolic syndrome (i.e. insulin resistance, excess adipose
tissue, hypercholesterolemia, etc.) are considered preventable risk factors through the
proper modification of an individual’s diet and incorporation of an exercise regime.
While the research is extensive with regard to FF health, performance, and exercise
(Abel, Mortara, & Pettitt, 2011; Dennison, Mullineaux, Yates, & Abel, 2012; Smith,
2011), to date, most studies on FF eating patterns are observational as opposed to
randomized control trials (Haddock, Day, Poston, Jahnke, & Jitnarin, 2015; Poston,
Haddock, Jahnke, Jitnarin, & Day, 2013). Similar to westernized diets, FF consume
excessive amounts of sodium, processed sugars, fatty snacks, and alcohol (Haddock et
al., 2015; Poston et al., 2013). This eating behavior is partly due to the demands of the FF
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work schedule which consists of sporadic night shifts and the need for quick, on-the-go
snacks. However, there is also reason to believe that most FF, like many Americans, are
uneducated as to healthy eating patterns and the positive effects proper nutrition can have
on health and performance. A recent study showed that most FF (~71%) do not follow
any specific dietary plan and over 75% of FF were interested in developing healthier
eating patterns (Yang, Farioli, Korre, & Kales, 2015). However, a large majority of the
FF questioned were unsure of the proper steps for implementing healthier eating patterns
into their professional and everyday lives. Provided these data, research is needed to
examine how proper nutrition counseling and a diet intervention could potentially
mitigate the components of metabolic syndrome and reduce the prevalence of CVD
expressed in FF.
Carbohydrate restricted diets (CRD) are diet alternatives being considered by
national health and nutrition organizations, such as the American Diabetes Association
and Academy of Nutrition and Dietetics, as a treatment for the metabolic components of
Syndrome X (Feinman et al., 2015; Franz et al., 2002). Although the scope of how a
CRD specifically impacts these metabolic markers is detailed further below; in short,
when an individual restricts carbohydrates (CHO), ingestion of both dietary protein and
fat increases, leading to an overall increase in satiety (Hu et al., 2016). A common
observation during CRD is decreases in total body mass and improvements in lipid
profiles, regardless of calories being held at requirements to maintain body mass or in an
ad-lib caloric fashion that results in a caloric deficit (Heatherly et al., 2017; Volek,
Fernandez, Feinman, & Phinney, 2008; Volk et al., 2014). Adherence is also a strong
component of any successful diet, given that a diet only has potential for success if an
2

individual can follow the provided guidelines. Research has consistently shown that
adherence to a CRD, ranging in customized prescription of allotted daily CHO intake, is
overall higher than other diets such as low fat, high CHO diets (Feinman et al., 2015).
Although many current CRD require severe CHO restriction resulting in a light to
moderate elevation in endogenous ketones, a CRD is technically defined as any diet
restricting CHO to below 26% of total caloric intake (Volek & Feinman, 2005; Volek et
al., 2008) or below 130 grams of CHO per day when advanced dietary tracking software
is not available to participants (Sato et al., 2017).
Present evidence suggests that a CRD could be a diet that FF would adhere to and
benefit from in regard to overall health. Specifically, one study recently surveyed over
3,500 FF concerning their dietary preferences and found diets (e.g. Mediterranean and
Paleo) low in CHO and high in animal meats were viewed more favorably (~65%) by FF
than diets based solely on vegetables or were extremely low in fat or CHO (< 10% for
either macronutrient) (Yang et al., 2015). Ideally, a caloric restricted diet might be the
overall best option for this particular occupation due to its simplistic nature and brief
duration. However, research has shown individuals in the presence of “trigger” foods,
specifically sugar (Avena, Rada, & Hoebel, 2008), then restriction of those trigger foods
(Astrup, Larsen, & Harper, 2004) along with healthy food choice counseling (A. D.
Association, 2002) is required for successful adherence to any diet. This is due to a
particular food “addiction” known as hedonic hunger and is commonly observed during
caloric restricted diets, resulting in low success rates pertaining to chronic weight-loss
and adherence (Appelhans, 2009; Berthoud, Münzberg, & Morrison, 2017; Lowe &
Butryn, 2007; Stroebe, Papies, & Aarts, 2008). A CRD, by its macronutrient
3

requirements, removes the overconsumption of highly processed sugars that have been
observed in FF (Haddock et al., 2015). By comparison, restricting calories expresses only
one major limitation: another limitation is the eventual regain in bodyweight, as observed
in the TODAY study where individuals followed a caloric restricted diet for over a 2-year
period and regained all of their original bodyweight back (Diabetes Prevention Program
Research Group, 2002). As detailed by Hall and Guo (2017), even when calories are
reduced, the body compensates by not only reducing caloric expenditure through other
processes (detailed further below), but also by upregulating hunger hormones and
initiating a feeding response (Hall & Guo, 2017). The end results are individuals who eat
more and move less due to the hypothalamic signaling processes recognizing the caloric
deficit the diet creates. Rather than slowly reintroducing calories back to the body,
calories are usually introduced quickly in a binge fashion and all while the metabolic
regulating hormones such as thyroxin are still significantly low. This combination results
in the individual obtaining a weight higher than when they first started the diet, known as
the rebound effect (Sumithran & Proietto, 2013). A recent review paper examining
dietary macronutrient composition and loss of fat mass found increasing dietary protein
intake is the key macronutrient for maintaining lean muscle mass and reducing adipose
tissue (Campbell et al., 2007). Thus, the last variable remains the manipulation of either
decreasing CHO or fats. Given genotype research has shown that a majority (~70%) of
the population responds metabolically (i.e. lipid and inflammation markers) more
favorably to a CRD than a low fat diet (Krauss, 2005), the present study will aim to
utilize a CRD to improve cardiometabolic markers in FF.

4

Therefore, provided these findings, the purpose of the present investigation is to
examine the effects of a 28-day CRD on metabolic and performance markers in career
male FF. These findings might offer insight into new dietary approaches for combating
and mitigating the number one cause of death among the nation’s FF.
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CHAPTER II
LITERATURE REVIEW
An Introduction to Cardiovascular Disease
By the year 2030, heart disease is projected to be the third leading cause of
mortality rates worldwide with over 23 million individuals dying from CVD-related risk
factors (Mathers & Loncar, 2006). In agreement with current statistics, the American
Heart Association (AHA), a leading organization for CVD risk prevention, found nearly
70% of all American adults over 20 years old are overweight and of that population, 35%
are obese (body mass index (BMI)  30 kg/m2; Go et al., 2014). Aside from a high BMI,
the AHA has identified common risk factors related to CVD, to include the following:
elevated serum cholesterol ( 240 mg ⋅ dL), hypertension (> 120/80 mm Hg), fasting
plasma glucose ( 100 mg ⋅ dL-1), use of tobacco, and/or leading a sedentary lifestyle (Go
et al., 2014).
Cardiovascular Disease and Nutrition
Current recommendations from the AHA for preventing and mitigating CVD
involve individuals working toward a variety of goals to maintain a healthy lifestyle. The
AHA and American College of Sports Medicine (ACSM) defined these goals in 2013, to
include: individuals burning more calories than calories consumed, following a dietary
approach to stop hypertension (DASH) diet, participating in (75-150 min) a week of
6

moderate-to-vigorous intensity aerobic exercise, respectively, and eliminating smoking or
secondhand smoking (Eckel et al., 2014). However, the recent HELENA study found the
allotted ACSM physical activity requirements (both duration and intensity) to be not
stringent enough to make noticeable changes on markers of cardiovascular health, as the
findings claimed that physical activity of low intensity, as measured by accelerometer,
did not differ significantly from television viewing in terms of cardiometabolic risk
factors (Barker et al., 2017). Further, organizations such as the AHA, the National Heart,
Lung, and Blood Institute, and the United States Department of Health and Human
Services all recommend a similar set of dietary guidelines which places emphasis on
reducing total caloric intake of dietary fats, especially those consisting of saturated fats
(SFAs; DeSalvo, Olson, & Casavale, 2016; Larosa et al., 1990). Similar to the physical
activity recommendations, the growing work of scientific literature is showing
discrepancies among emerging data and the current dietary guidelines; this discrepancy
may be exhibited most notably the high-fat DASH study (Chiu et al., 2015). Chiu and
team randomized participants to either a low-fat or high-fat DASH diet. Although both
diets significantly reduced both systolic (SBP) and diastolic blood pressure (DBP), it was
only the high-fat DASH diet which yielded significant improvements in plasma
triacylglycerols (TAG) and very-low density lipoprotein (VLDL-c) particle size. These
data, among others, are in disagreement with the Framingham Heart Study and Seven
Countries Study of Ancel Keyes from the early 1950’s which form the cornerstones for
dietary guidelines today and the diet-heart hypothesis.
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Origin of the Current Dietary Guidelines
The Framingham Heart Study set out to determine common CVD characteristics
among adult men and women. After collecting data from over 5,000 participants and with
the Framingham study still ongoing today, some common risk factors found were high
BP, high cholesterol, excess adipose tissue, and physical inactivity. Although the
Framingham Study provided science with the important role that high density
lipoproteins (HDL-c) play in reducing CVD, researchers also concluded heart disease and
consumption of dietary fat were significantly increased in individuals due to the
relationship between the participants’ cholesterol levels, circulating plasma levels of
TAG, and risk for developing heart disease (Castelli, 1984; Castelli, 1986; Wilson, 1994).
Following the Framingham Study, the Seven Countries Study set out to examine the
association of diets and corresponding risks for developing CVD across a multitude of
cultures. In a similar manner as the Framingham Study, the findings of the Seven
Countries Study showed blood cholesterol and SFAs ingestion followed a linear path and
subsequently increased the risk for developing any form of coronary heart disease (CHD;
Keys et al., 1984; Keys et al., 1986; Verschuren et al., 1995). It was these findings the
AHA then implored in developing its heart healthy nutritional guidelines for minimizing
dietary fat and cholesterol-containing foods in order to mitigate hypercholesterolemia.
Although both studies have been instrumental in providing evidence for the prevention of
CHD, recent literature shows there were also incorrect conclusions drawn from the
findings of both studies.
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Problems in the Current Research Paradigm. Specifically, research from the
University of California Los Angeles monitored total cholesterol (TC), BMI, HDL-c and
LDL-c, as well as total TAG in 1,134 hospitalized patients, and found that low TC (<129
mg/dL) was most closely associated, although not causative, with an increased risk for
heart failure (Horwich, Hamilton, MacLellan, & Fonarow, 2002). Moreover, a recent
meta-analysis called to question the current dietary guidelines when the relationship
between dietary fat, serum cholesterol, and CHD was examined in ten separate,
randomized controlled dietary intervention trials, and found no relationship for reducing
dietary fat and CHD risk (Harcombe, Baker, DiNicolantonio, Grace, & Davies, 2016).
Further, the AHA has recommended the replacement of SFAs with polyunsaturated fats
(PUFAs) and CHO. However, the data are clear that replacement of SFAs with CHO
generally results in minimal changes for CHD risk and can even increase an individual’s
risk for developing CVD (Siri-Tarino, Chiu, Bergeron, & Krauss, 2015).
Calories In vs. Calories Out. A current dietary protocol of the AHA and ACSM
for improving CHD risk factors is an emphasis on weight reduction via “calories in vs.
calories out.” Given the higher caloric load of a TAG (9 kcals/gram) versus both protein
and CHO (4 kcals/gram), leading health organizations have implemented guidelines
reducing dietary fats to meet the need for creating a greater energy deficit in Americans.
With regard to successful and sustainable weight-loss, caloric expenditure must exceed
caloric intake, regardless of diet macronutrient composition (Buchholz & Schoeller,
2004; Schoeller & Buchholz, 2005; Wing & Hill, 2001; Wing & Phelan, 2005). In
contrast to the beneficial aspects demonstrated by calorie monitoring (Hartmann‐Boyce,
Johns, Jebb, & Aveyard, 2014), the approach of calorie counting and recommended
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reductions in dietary fat have not slowed the steadily increasing number of overweight
and obese individuals (Chan, 2017). The prevalence of weight gain can be partially
attributed to the misconception that the aforementioned guideline implies, which is all
calories are created equal. A sole focus on caloric density ignores the neuroregulation
different macronutrients have on the hypothalamic and hedonic regions of the brain.
Although removal of dietary fats for CHO can reduce total caloric load acutely,
chronically, an increase in CHO in an individual’s diet can alter the dopamine-mediated
responses to food as well as the chemical-hormonal messaging taking place during
digestion. Specifically, when individuals consume meals of high glycemic load and
minimal dietary fat or protein content, secretion of glucagon-like peptide 1 (GLP-1)
signals for the production of insulin and is represented with an inverse relationship to
insulin (Norouzy, Leeds, Emery, & Bayat, 2009). Aside from leptin and insulin, intestinal
secretion of GLP-1 and cholecystokinin (CCK) are the immediate satiety hormones,
given the ability of both hormones to mitigate gastric emptying. However, the diminished
response from GLP-1 and reactive hypoglycemic crash following a high glycemic meal
results in an attenuated feeling of fullness and, chronically, is a potent appetite stimulus
leading to excessive caloric consumption and eventual weight gain (Waldman, Krings,
Smith, & McAllister, 2018). With regard to dietary fat, research has shown a moderate
bolus of TAG to cause an increase in CCK levels, which is known to immediately induce
satiety, reduce meal size, and decrease total caloric consumption (Lee, Schiffman, &
Pappas, 1994). Satiety scales developed by examining the caloric requirements for the
gastric emptying rates of different macronutrients, rank protein as the most filling
macronutrient followed by fibrous CHO, then TAG, and lastly, highly processed CHO
10

(Kessler, 2010). The Centers for Disease Control and Prevention showed most Americans
are consuming CHO from highly processed foods such as cereals, granola bars, and soda
drinks (Ervin & Ogden, 2013). Therefore, given the strong correlation between excessive
adiposity and CHD as shown by the AHA (Eckel & Krauss, 1998) and the calorie in vs.
calorie out model that the AHA recommends for the prevention of CVD, it can be
hypothesized macronutrient composition -- specifically protein and fat, not just caloric
expenditure -- does matter in the prevention and treatment of CHD.
An Overview of Dietary Lipids
Classification/Structure
Molecularly, lipids are a diverse group of hydrophobic, organic-solvent-soluble
compounds that are generally not water-soluble. Their primary structure consists of a
hydrocarbon core (i.e. fatty acids and steroids) which can also possess a polar,
hydrophilic group or head [R-(CH2)nCOO-]. Unlike proteins and CHO, which both form
covalent interactions, lipids associate through non-covalent forces (Palsdottir & Hunte,
2004). Non-covalent forces and the Van der Waals interaction between two or more
hydrocarbon regions allow lipids to participate in a multitude of roles such as energy
storage, membrane integrity, cell signaling, and hormone regulation (Mougios, 2006).
Fatty acids are classified by a hierarchical process, the first of which begins with
the length (i.e., short, medium, long, or very long) of a fatty acids chain (C:2 to C:24) and
can occur naturally in two forms: saturated or unsaturated. The degree of unsaturation is
dependent on the number of double bonds occurring between carbon molecules and are
grouped as saturated (SFA; no double bonds), mono-unsaturated (MUFA; 1 double
bond), and poly-unsaturated (PUFA; 2 or more double bonds). Moreover, the orientation
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of double bonds can further classify a fatty acid to either a cis or trans group. Unlike a
trans fatty acid where the functional group occurs on the opposite side, a cis fatty acid
has its functional group on the same side, allowing for the insertion of a bend into the
hydrocarbon tail -- generally the fatty acids found in nature (Mougios, 2006). Lastly, fatty
acids are classified on esterification status to glycerol and availability for oxidation,
either as a glyceride (glycerol attached) or as a non-esterified fatty acid (NEFA) (glycerol
absent), also known as a free fatty acid (FFA) (Mougios, 2006). Within the scientific
literature, fatty acids are referred to by a system of abbreviations such as: 18:3c9, where
18 designates the total number of carbons, 3 designates the number of double bonds,
followed by a “c” or “t” denoting either cis or trans fatty acid, respectively, and then a
final number (9) representing where the double bond starts within the fatty acid chain
(Mead, 1986).
Organization of Triacylglycerols
Complex lipids known as a TAG are characterized by three separate fatty acid
chains attached to a glycerol backbone. Rarely are the three fatty acid chains of the same
carbon length, but are usually composed of three mixed fats, including saturated and
unsaturated fatty acids (Mead, 1986; Vance & Vance, 2008). Among the three
macronutrients, oxidation of TAG produces the greatest quantity of energy because
unlike either CHO or proteins, the carbons of a TAG predominately exist in a reduced
state and therefore, are efficient in the storage of energy (Mead, 1986). Quantitative
analysis in previous literature has shown most of the carbons found in TAG are more
highly reduced than those of CHO, due to their placement near the reduced methyl level;
thus, oxidation of a TAG consumes more oxygen than a CHO, resulting in a greater
12

release of metabolic energy (Mead, 1986; Vance & Vance, 2008). It is due to this vast
difference in energy yield and storage that TAG are the primary substrate for energy
while at rest and during low-moderate exercise intensities (50-65%) of maximal oxygen
consumption (V̇O2 max) (Juul Achten, Gleeson, & Jeukendrup, 2002; Coyle, 1995; van
Loon, Greenhaff, Constantin-Teodosiu, Saris, & Wagenmakers, 2001). Aside from
energy production, TAG also serve the purpose of heat production, as found in brown
adipose tissue, and for thermal insulation of organs (Cannon & Nedergaard, 2004; R. A.
Young, 1976).
Digestion
Dietary TAG digestion poses a problem unlike proteins or CHO due to its
hydrophobic structure. Making lipids readily available for breakdown, absorption, and
transportation requires the release of bile salts -- the amphipathic make-up of which can
actively emulsify and expand the surface area for the digestion of dietary lipids.
However, given the storage of bile salts in the gallbladder, a network of signals must
exist to allow feedforward control of this compound. Upon entering the oral cavity, lipids
are sensed by taste bud receptors lining the tongue and walls of the mouth. Salivary
lipase, which initially begins the digestive process of a lipid, generates chemical signals
to the brainstem which are then dispersed in a bidirectional system. Although the data are
not fully clear on the final destinations of either neuronal signal, present literature
speculates one set of chemical messengers travels by way of the gut-brain vagal nerve
and signals for the release of cholecystokinin (CCK) and secretin, resulting in bile salt
release and delayed gastric emptying (Froehlich, Gonvers, & Fried, 1995; Green,
Taguchi, Friestman, Chey, & Liddle, 1989). The second set of messengers travels first to
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the caudal brainstem and then to the hypothalamic and hedonic regions where they merge
with information from the gut and digestive organs to prompt neurotransmitters to initiate
a satiety response, usually through the downregulation of Neuropeptide Y (Beck,
Stricker-Krongrad, Burlet, Nicolas, & Burlet, 1990). Upon entering the stomach, lingual
lipase begins the process of lipolysis and conversion of an intact TAG to a mixture of
glycerol, FFA, mono, and diacylglycerols (Liao, Hamosh, & Hamosh, 1984). The
remaining mixture then enters the lumen of the small intestine and -- because of the
partly hydrophilic structure these particles now have due to bile salts -- micellar particles
form to enable absorption through intestinal mucosal cells.
Absorption
Cellular uptake of micellar particles and TAG re-formation from the hydrolyzed
products is dependent on the chain length of the FFA and takes place in the endoplasmic
reticulum and Golgi complex of the intestinal cells. Re-esterification requires FFA of 10
carbon atoms or greater to be activated first by the enzyme acyl CoA synthetase, due to
the high specificity for long chain fatty acids only (Mead, 1986). If the number of carbon
atoms of a FFA is less than 10 (generally short and medium-chain FFA) the activation
step is bypassed and the FFA enter directly into the portal vein, bound by the protein
albumin, and are then facilitated to the liver. However, esterification of a long chain FFA
into a TAG is then dumped into the lymphatic system, bound to a lipoprotein carrier
known as a chylomicron.
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Transportation
All dietary lipids are transported in the circulatory system, from tissue to tissue,
by a lipoprotein. Lipoproteins are classified with respect to their density, as determined
by centrifugation, and are dependent on the concentration of lipids and specific
polypeptides within a given protein carrier. Lipoproteins of high, moderate, and low lipid
concentrations differ in their lipid-carrying roles with respect to the origin and synthesis
(i.e. exogenous or endogenous) of each specific TAG (Mead, 1986). The primary
lipoprotein carrier for exogenous dietary TAG are chylomicrons. Chylomicrons transport
TAG to non-hepatic tissues -- specifically adipose tissue, the heart, and skeletal muscles - to be either immediately oxidized for cellular energy or stored for later utilization.
Storage
Lipogenesis predominately occurs within adipose tissue during periods of overnutrition. After a TAG has been transported by a chylomicron, apoprotein C-II activates
lipoprotein lipase, which then catalyzes the hydrolysis of a TAG to glycerol and FFA
(Mougios, 2006). Upon FFA entry into the adipocyte, a TAG is once again re-synthesized
for storage while the glycerol is shuttled to the liver for glucose re-synthesis. However,
due to adipose tissue’s lack of the enzyme glycerol kinase, the backbone (i.e. glycerol-3phosphate) for a TAG must come from glycolysis (Mead, 1986). However, the
expandability of adipose tissue is not an unlimited process and lipotoxicity, or the
spillover of excessive TAG, can occur in response to a positive energy balance (Slawik &
Vidal-Puig, 2007). Therefore, given the average adipocyte of non-obese individuals is 0.1
mm in diameter and 0.05 µg in mass (Salans, Cushman, & Weismann, 1973), a typical fat
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cell is only capable of storing 0.7 ± 0.2 μmol ⋅ kg lipid (Ali et al., 2011) and anything
exceeding this potentially leads to an increase in circulating fatty acids or hyperplasia.
Metabolism
During periods of energy generation, when caloric expenditure is exceeding
caloric intake, organisms catabolize fat (i.e. lipolysis) to meet the energy demands. The
complete hydrolysis of a TAG will yield a glycerol backbone, along with three fatty
acids. Lipolysis is controlled hormonally by the enzyme hormone-sensitive lipase (HSL),
adipose triglyceride lipase (ATGL), and monoacylglycerol lipase (MGL) whose activity
is also significantly regulated by the hormone insulin (Strålfors, Björgell, & Belfrage,
1984). Before oxidation of FFA can occur, mobilization must first take place. ATGL is
the first enzyme to catalyze the lipolysis reaction by hydrolyzing the ester linkage
between the FFA chains and glycerol backbone and generating a diacylglycerol. After the
removal of perilipin by protein kinase A, phosphorylated HSL catalyzes the second step
of mobilization by hydrolysis of the diacylglycerol and creating a monoacylglycerol. The
last step of lipolysis is the enzyme MGL catalyzing hydrolysis and effectively releasing
the final FFA. The release of the three FFA are passively diffused through the cell
membrane where they are then bound to the plasma transporter albumin and carried to
peripheral tissues for a process collectively known as -oxidation.
-oxidation occurs within the mitochondria of a cell; however, FFA must first be
activated by the acetylation of coenzyme A, reducing FFA to fatty acyl CoA. Activation
of a FFA to fatty acyl-CoA by coenzyme A requires two ATPs, due to the energy
requirements of cytoplasmic fatty acyl-CoA synthetase, which initiates the reaction and is
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specific to the chain length of the FFA attempting to gain entry to the mitochondria
(Gropper & Smith, 2012). Aside from short-chain FFA, medium and long chain FFA
must cross the mitochondrial membranes utilizing a transport system. The first step of
transporting fatty acyl CoA across the mitochondrial membrane complex involves the
covalent bonding of the fatty acyl moiety to a transporter known as carnitine. This step is
initiated by the transferase enzyme carnitine acyltransferase I (CAT I) whose active site
faces the cytoplasm of a cell (Mead, 1986). Following the translocation of CAT I from
the outer mitochondrial membrane to the inner membrane, a second transferase known as
carnitine acyltransferase II (CAT II) completes the transport process by exchanging the
tightly bonded fatty acyl-carnitine for free carnitine and fatty acyl-CoA which is released
into the mitochondrial matrix. Once in the matrix, oxidation takes place at the -carbon,
hence the term -oxidation, and results in the fatty acyl-CoA chain being shortened by
two-carbon units each time. Each two-carbon unit is released in the form of acetyl-CoA
where it can then enter the tricarboxylic acid cycle (TCA) for further oxidation (Gropper
& Smith, 2012).
Furthermore, -oxidation is tightly regulated by several rate-limiting enzymes
(RLE). The first enzyme is known as acyl-CoA dehydrogenase which catalyzes the first
rate-limiting step of -oxidation and is responsible for the removal of two hydrogen
atoms using the redox acceptor Flavin Adenine Dinucleotide (FAD). The second ratelimiting step to -oxidation involves the enzyme -hydroxyacyl-CoA dehydrogenase;
this step removes one hydrogen and binds to the redox cofactor Nicotinamide Adenine
Dinucleotide (NAD), which can then donate its hydrogen to the electron transport chain
(ETC) to undergo oxidative phosphorylation. The final rate-limiting step to -oxidation
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involves the enzyme thiolase which effectively cleaves the - bond from 3-ketoacylCoA, producing only acetyl-CoA for the TCA (Gropper & Smith, 2012; Mead, 1986;
Mougios, 2006; Vance & Vance, 2008). All three RLE are regulated by several mediators
including: elevated levels of ATP, hydrogen ions, acyl-CoA carboxylase (ACC),
available NAD and FAD cofactors, and citrate levels (Gropper & Smith, 2012; Mead,
1986).
Macronutrient Manipulation
With regard to metabolic health, a shift has occurred over the last decade in our
understanding of dietary macronutrient manipulations and lipid metabolism (Liebman,
2014; Volek et al., 2008; Volek, Phinney, et al., 2009). Specifically, present ongoing
investigations are examining the relationship between the reduction in exogenous CHO
ingestion and its effects on CVD risk. Numerous studies have purported the benefits of
light-moderate CHO restriction on improving variables such as weight-loss (Grieb et al.,
2008; Volek et al., 2008; Volek et al., 2002), improvements in atherogenic dyslipidemia
(Volek et al., 2008), hyperinsulinemia, and type II diabetes (Volek & Feinman, 2005;
Volek et al., 2002), as well as characteristics of the metabolic syndrome (Volek, Ballard,
et al., 2009; Volek & Feinman, 2005). Although similar findings have been found in
investigations which have examined like dependent variables using caloric restriction and
low-fat high-CHO diets as its model (Golay et al., 1996; Opie, 2009; Redman &
Ravussin, 2011), a previous study by Draznin and team showed a CRD was significantly
more effective at increasing the cellular expression of the mitochondrial transcription
factor peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1)
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and cellular sensor adenosine monophosphate kinase (AMPK) in both a caloric surplus
and caloric deficit, compared with a low-fat, high CHO diet (Draznin, Wang, Adochio,
Leitner, & Cornier, 2012). This finding suggests CHO restriction has benefits
transcending merely skeletal substrate metabolism. In light of the current research, the
physiological benefits to CHO restriction will be detailed further.
Characteristics of a Carbohydrate Restricted Diet
As of recently, agreement upon common parameters for defining a CRD has
eluded the scientific community and resulted in a constant barrier for communication.
This might be partly explained due to the severity of CHO restriction being implemented,
as studies have shown a multitude of alterations in mitochondrial enzymatic expression
with varying levels of CHO manipulations. Feinman et al. and others have proposed a set
of definitions which were based on similar dietary parameters in multiple studies: 1) a
very low CHO ketogenic diet is one limiting CHO intake to less than 50 grams per day
(g/d) or less then 10% of the 2000 kilocalories per day (kcal/day); 2) a non-ketogenic,
CRD, also known as a low CHO, high fat (LCHF) diet, is a diet which limits CHO intake
to less than 26% of total caloric energy; 3) a moderate CRD allows for CHO intake
between 26% and 45%; 4) a high CHO diet or western diet (WD), as recommended by
the ADA, allows CHO intake above 45% (Feinman et al., 2015; T. D. Noakes & Windt,
2017). It should be pointed out that the term CHO restriction is becoming more
acceptable within the literature, as opposed to LCHF. It has been observed from our own
laboratory that fat intake is generally consumed at around 30-40% in a typical WD and
rarely is there need for the individual to increase dietary fat in their own diet (Waldman et
al., 2017). Therefore, during periods of CHO restriction, protein ingestion increases and
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dietary fat naturally becomes the dominant oxidized substrate and thus, is in agreement
with the Law of Mass Action. It is important to note that although protein ingestion
increases, dietary fat is the macronutrient which characterizes the greater percentage of
the CRD given its higher calorie-per-gram content, and is why studies show an increase
in oxidative and lipolytic enzymes -- not proteolytic enzymes -- within 5-days of
reducing CHO intake (Goedecke et al., 1999).
Metabolic Flexibility
Previous research examining the interplay between macronutrients and
components of the metabolic syndrome concluded that regardless of nutrient
composition, excessive exposure of nutrients to cells results in what is termed
mitochondrial dysfunction and metabolic inflexibility (Wisse, Kim, & Schwartz, 2007).
This inflexibility was first considered when a series of studies demonstrated the
inefficiency with which the mitochondria of individuals displaying characteristics of the
metabolic syndrome were unable to effectively use FFA as a fuel source and were
“stuck” in a glycolytic flux cycle (Kelley, Goodpaster, Wing, & Simoneau, 1999; Kelley,
Mokan, Simoneau, & Mandarino, 1993; Kelley & Simoneau, 1994). It is known
excessive lactate (La-), referred to as lactatemia, is a product of continuous glycolysis and
has been shown to effectively inhibit FFA oxidation by inhibiting the FFA transporter
CAT 1 and by reducing lipolysis through a G-coupled receptor (GPR81; Cai et al., 2008;
Liu et al., 2009). This was also recently demonstrated when a study attempted to show
metabolic flexibility indirectly through correlation of blood La- levels, fat, and CHO
oxidation responses during the peri-exercise window (San-Millán & Brooks, 2017).
Subjects expressed a spectrum of metabolic capabilities ranging from those with
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metabolic syndrome (V̇O2max = 26.9  10.5 mL·kg-1·min-1) to elite, international-level
cyclists (V̇O2max = 74.1  4.7 mL·kg-1·min-1). The findings showed two important
concepts relevant to mitochondrial flexibility: 1) Individuals who expressed components
of the metabolic syndrome had similar La- levels at rest compared to those of professional
athletes when cycling at 300 Watts (W), 2.0 vs. 2.5 mmol.L-1, respectively, (San-Millán
& Brooks, 2017); 2) Individuals who were categorized with metabolic syndrome also
showed a very strong inverse relationship (r = -0.97, p < 0.01) between fat oxidation rates
during exercise and La- levels (San-Millán & Brooks, 2017). These findings further
conclude individuals whom lack mitochondrial flexibility and express metabolic
dysfunction are unable to adequately oxidize FFA due to a host of feedforward processes
which effectively inhibit both the TCA and oxidative phosphorylation.
Moreover, there is current literature which argues the composition of
macronutrients, specifically CHO, does matter with regard to mitochondrial dysfunction,
given its unique alterations to lipid metabolism and insulin when ingested (Volek et al.,
2008). Among the three major macronutrients, CHO are the only major non-essential
substrate, due to the physiological production of ketone bodies and regulatory hormones
maintaining blood glucose during periods of low CHO availability. Rather, dietary CHO
play a significant role in determining substrate availability and subsequently, oxidation
rates. After ingestion, CHO signals for the secretion of insulin, a key storage and
regulatory hormone for all three macronutrients (Saltiel & Kahn, 2001). Insulin is a
powerful hormone which affects multiple downstream pathways including peripheral
glycolysis, lipolysis, lipogenesis, gluconeogenesis, and glycogenolysis. With regard to
substrate oxidation, insulin is able to directly inhibit CAT I and CAT II, HSL, AMPK,
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and increase the activities of ACC and fatty acid synthase (FAS; Moustaid, Beyer, & Sul,
1994; Stephens, Constantin‐Teodosiu, & Greenhaff, 2007; Witters & Kemp, 1992). This
is an important concept given that a reduction of CHO can result in a major perturbation
to the regulatory mechanisms which attempt to maintain homeostasis; this disturbance
signals for a multitude of transcriptional and enzymatic changes, which affectively shifts
the mitochondria back to a state of flexibility. Additionally, these changes have even
been observed at the molecular level in acute settings (< 5 days) where CHO was
restricted from 49% of total energy intake to only 34%. By Day 3, almost 400 out of
18,861 transcriptional genes involved in FFA oxidation were upregulated within skeletal
muscle tissue (Sparks et al., 2006). Of these transcriptional factors, arguably the most
significant two are CHO response element binding protein (ChREBP) and sterol response
element binding protein 1c (SREBP-1c). An increase in TAG plasma appearance has
been contributed to SREBP-1c as the primary de novo lipogenic transcription factor when
high levels of glucose are in circulation (Lin et al., 2005). Furthermore, ChREBP
exacerbates the effects of SREBP-1c by upregulating ACC and FAS, thus, further
promoting de novo lipogenesis (Ishii, IIzuka, Miller, & Uyeda, 2004). The research is
clear in determining the existing links between excessive dietary CHO intake, insulin,
and subsequent signaling in cellular health and function.
Cardiometabolic Responses to Carbohydrate Restriction
A cascade of metabolic and hormonal accommodations occurs to meet the
decreased flux of glucose during a CRD. These changes are controlled and monitored by
the higher hedonic centers and hypothalamic region (Ziauddeen, Alonso-Alonso, Hill,
Kelley, & Khan, 2015). Although the hormones insulin and cortisol are both directly
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affected by the lack of CHO intake, there is evidence for indirect adaptations which result
in improved CVD risk factors such as TAG levels, lipid profiles, body composition, body
mass index (BMI), resting blood glucose, CRP, and BP.
Insulin Responses
Insulin is a peptide hormone secreted by the -cells of the pancreas in response to
excess blood glucose. Insulin serves the body in a variety of roles: facilitating glucose
uptake through the upregulation of GLUT-4, controlling of CHO, FFA, and protein
metabolism, as well as promoting cellular growth and division. In normal and healthy
individuals, insulin is released in a biphasic manner following the ingestion of a meal
(Bratanova-Tochkova et al., 2002). However, chronically elevated insulin levels produce
a mitigated biological response known as insulin resistance (IR) (Cefalu, 2001). During
IR, the receptor becomes resistant to the insulin polypeptide substrate, resulting in
impaired sensitivity and an attenuated rate of glucose disposal (G. Reaven, 2004). Over
time, IR will cause the -cells of the pancreas to over secrete insulin in order to maintain
proper glucose levels, resulting in a disrupted pathophysiological condition known as
compensatory hyperinsulinemia (Wilcox, 2005).
Hyperinsulinemia and elevated blood glucose levels have both been suggested as
the predominant mechanisms for the facilitation of all other metabolic markers which
make up the metabolic syndrome (Syndrome X; Lakka et al., 2002; G. M. Reaven, 1993).
Moreover, individuals whom have been diagnosed with hyperinsulinemia are at a
significantly greater risk of developing some form of CHD, independent of diabetes
diagnosis (Ginsberg, 2000). These findings are of particular interest given the Federal
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Emergency Management Agency (FEMA) showing in a previous study that sudden
cardiac death is the leading cause of death in career FF; moreover, out of almost 300 FF,
glucose and insulin levels were significantly correlated with coronary vascular lesions
and artery calcium scoring suggesting participants who expressed these symptoms were
at a higher risk for CHD (Superko et al., 2011). It is reasonable to assume the beneficial
effects of CHO restriction used in studies with subjects exhibiting risk factors of the
metabolic syndrome can be applied to FF as well, given similar metabolic characteristics
(Donovan et al., 2009).
With regard to CHO restriction, hormone responses, and CVD risk, insulin is
arguably the primary dependent variable observed among the literature. Given that a
bolus of glucose ingestion raises blood glucose levels and subsequently insulin, the
removal of dietary CHO should result in a decreased need for insulin secretion and
improved insulin sensitivity. Medical practitioners have voiced these exact findings with
utilizing CHO restriction in patients who have been diagnosed with metabolic syndrome
and tapered those individuals off by as much as 150 units of insulin per day within an 8
day period (Westman & Vernon, 2008). Therefore, it is reasonable to assume individuals
who express metabolic syndrome characteristics, like FF, would show improvements in
resting insulin levels within a 30-day duration period when following a CRD (Waldman
et al., 2017).
Cortisol Responses
Cortisol is a glucocorticoid produced by the adrenal glands during times of stress
and in response to low blood glucose levels. The primary pathways through which
cortisol is secreted is the hypothalamus-pituitary-adrenal (HPA) axis and
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sympethoadrenal axis (SA) (Schaeffer & Baum, 1984). Cortisol upregulates lipolysis,
glycolysis, proteolysis, glycogenolysis, and gluconeogenesis when synthesized and
ensures adequate substrates are available for oxidation depending on the stimulus from
either the internal or external environment. Acutely, secretion of cortisol in healthy
individuals plays an important role in maintaining metabolic homeostasis, the facilitation
of recovery, and promotion of favorable skeletal and cellular adaptations for survival
known as allostasis (Franklin, Saab, & Mansuy, 2012; Selye, 1955). In an occupation
such as firefighting, an acute stressor can result in secretion of cortisol, as well as other
glucocorticoids and catecholamines, and is a beneficial process which prepares the body
for “fight or flight” (Jansen, Van Nguyen, Karpitskiy, Mettenleiter, & Loewy, 1995).
However, chronic exposure to stress has been proposed as a major contributor to the
development and progression of CVD (Walker, 2007). Although the degree of sensitivity
differs among individuals, research shows peripheral tissues are highly receptive to
glucocorticoid secretion by way of increasing vasoconstriction and substrate storage
(Walker, Best, Shackleton, Padfield, & Edwards, 1996; Walker et al., 1998).
Metabolically, insulin and cortisol are antagonistic hormones, and during acute periods of
CHO restriction (< 5 days), counteract one another (Waldman et al., 2017). In overweight
or obese individuals who express symptoms of metabolic syndrome and insulin
resistance, the chronic elevation of glucose and suppression of insulin can lead to cells
starved of glucose. The net result is chronically elevated levels of cortisol which
effectively makes available additional glucose molecules via its action as a
glucocorticoid. (Stolk, Lamberts, De Jong, Pols, & Grobbee, 1996). Further, chronic
elevation in cortisol is a known mechanism for insulin resistance by way of decreasing
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the transcription, binding, and coding of the insulin receptor substrate (IRS) (Ferris &
Kahn, 2012). The net result is excessive weight-gain from chronic upregulation of fatty
acid synthase, an increase in LPL activity, and excessive nutrient availability due to
cortisol’s ability to create lysis of all major macromolecules and metabolic pathways
detailed earlier.
Caloric restriction from any macronutrient, acutely ( 3 weeks), increases cortisol
(Tomiyama et al., 2010). It has further been shown that a significant reduction in CHO
will result in: increased cortisol output (McMahon, Gerich, & Rizza, 1988), decreased
thermogenesis using the adrenal hormone triiodothyronine (T3) as its marker (Spaulding,
Chopra, Sherwin, & Lyall, 1976), impaired mood (Brinkworth, Buckley, Noakes, Clifton,
& Wilson, 2009), and suppressed immune function (Gleeson & Bishop, 2000). Cortisol
and T3 are tightly regulated by one another and together are used as a marker for
metabolic health. Elevated cortisol is known to lower thyroid stimulating hormone (TSH)
and subsequently, inhibits the conversion of the inactive form of T4 from becoming
active by way of reverse T3 (Walter et al., 2012). When researchers have restricted CHO
or calories in subjects, T3 was significantly decreased, therefore suggesting the role of
CHO in maintaining a properly functioning metabolism is essential (Kose, Guzel, Demir,
& Arslan, 2017; Spaulding et al., 1976). However, since the findings regarding CHO
restriction and T3 from Phinney et al. (1983) demonstrating normal metabolic rates
without associated hyperthyroidism, it has been argued that the reduced T3 levels
observed in CHO restricted studies are not a result of a dysfunctional metabolic system,
but rather a result of the cells becoming more metabolically efficient and requiring less
T3 for thermogenesis (Phinney, Bistrian, Wolfe, & Blackburn, 1983). While further
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studies are needed, it can be reasonably argued that CHO restriction induces a unique
metabolic adaptation exceeding the current understanding of macronutrient manipulations
on hormonal and biochemical responses. While only speculation, recent pilot data from
our laboratory suggests acutely applied (< 5 days) a CRD will cause an increase in
cortisol; however, once weight-loss becomes stable and cells have become “fat-adapted”,
cortisol will return to baseline values and insulin will remain significantly lower.
Collectively, these data suggest the individuals are transitioning towards a state of
metabolic flexibility without impairment to their metabolic rates.
Cholesterol & Lipids
Cholesterol is an essential phospholipid providing rigidity to cell membranes and
is a precursor to steroidal hormones. Synthesis of cholesterol occurs in the cytosol
through the enzyme hydroxymethylglutaryl-CoA (HMG-CoA) synthase and HMG-CoA
reductase which uses excess acetyl-CoA -- generally from excessive FFA availability -exported from the mitochondria and imported through either the Kandutsch-Russell
pathway or Bloch pathway, resulting in a new zoosterol (Kresge, Simoni, & Hill, 2005;
Wu, 2014). Since the Key’s study, much attention with regard to CVD has been given to
cholesterol as a strong marker for future plaque development and atherosclerosis. Briefly,
early studies demonstrated plasma levels of cholesterol and vascular adhesions were
more prominent in the cholesterol containing-group when rabbits and chickens were fed
either a high cholesterol or no cholesterol diet (Gould, 1951; Ignatowski, 1908). These
findings, along with observations that dietary fat, specifically SFA, increased plasma
LDL-c levels (Chiu, Williams, & Krauss, 2017), led to current nutrition
recommendations prescribing low-fat, low-cholesterol diets for individuals with
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components of the metabolic syndrome. However, the researchers which denounced
dietary cholesterol due to its negative effects on the heart, later announced cholesterol in
fact had little effect on cardiovascular health when examined in humans as opposed to
animals -- although this went largely ignored by the scientific community (Keys, 1953).
Although progress is currently being made, there is much debate as to how SFA might
increase cholesterol levels.
With regard to cholesterol homeostasis, much attention has been given to the
peroxisome proliferator-activated (PPAR) , /,  nuclear receptor transcription family
and availability of FFA. Though it would seem the PPAR family is sensitive to all FFA,
specifically SFA, myristic acid and stearic acid are both found to bind with especially
low affinity to the PPARs ligand binding pocket, thus, upregulating the PPAR nuclear
receptors (Varga, Czimmerer, & Nagy, 2011). While PPARs are regarded as antiinflammatory enzymes (Kapadia, Yi, & Vemuganti, 2008), excessive TAG synthesis in
the cytoplasm, as a result of high efflux from malonyl-CoA and subsequent over
expression of PPAR receptors, can result in ceramide production and essentially inhibit
the PPAR nuclear family (Wymann & Schneiter, 2008). These findings are important
because the PPAR family regulates excessive cholesterol uptake through HDL-c by
activation of the protein ATP-binding cassette transporter (ABCA1; Oram & Lawn,
2001).
Regardless of the cholesterol increasing mechanism, what researchers do agree
upon is LDL-c has the greatest capacity to be oxidized of all the lipoproteins
(Parthasarathy, Raghavamenon, Garelnabi, & Santanam, 2010). LDL-c are naturally
covered by a sheath of antioxidants which act to protect their lipid contents (Bowry,
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Ingold, & Stocker, 1992). During periods of LDL-c aggregation, this antioxidant system
is quickly oxidized, leaving LDL-c exposed to oxidative damage. The oxidized
apolipoprotein B (apo B) then becomes a chemical signal which is recognized by
macrophages as an inflammatory process occurring. Macrophages are attracted to the
damaged region and the collective gathering of LDL-c and its subsequent consumption
by macrophages result in foam cells (Moore, Sheedy, & Fisher, 2013). Foam cells then
attach to the lesion and harden, forming a plaque. Over time, the plaque is weakened by
the inflammatory process and eventually can break off resulting in a cardiac infarction.
However, investigators and dieticians are finding dietary modifications with CHO
restriction, regardless of the fat and cholesterol content, is proving a potent treatment for
individuals whom express hypercholesterolemia.
In a dose-response relationship, when dietary fat is replaced with CHO, hepatic
lipogenesis increases, and has been observed even when the diet remains isocaloric
(Aarsland & Wolfe, 1998; Parks, 2002). In a seminal study by Schwarz and colleagues,
de novo lipogenesis significantly increased when normoinsulinemic subjects confined to
a metabolic ward switched from a 5 day LCHF diet to an isocaloric low-fat high-CHO
diet (Schwarz, Linfoot, Dare, & Aghajanian, 2003). The mechanism for these findings
was attributed to insulin. When individuals are following a LCHF diet, insulin is
naturally low and even though the diet is high in dietary fat, low insulin allows for the
cells to become more lipolytic. However, when individuals switched over to a similarly
calorically matched low-fat, high-CHO diet, insulin was increased, resulting in an
increase in malonyl-CoA and excess glycerol backbones for TAG synthesis from the
limited storage capacity for CHO. These findings, along with earlier discussions about
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downregulation of PPARs due to excessive FFA binding and increased cholesterol
markers, collectively suggest why a CRD can favorably alter hypercholesterolemia and
dyslipidemia. Numerous studies have shown CRD differing in duration (1-12 mo) and ad
lib and/or hypocaloric intake, generally outperform similar low-fat high-CHO diets in
lipid variables, with the mean relative responses across the CRD resulting in differences
of TAG (22%), LDL-c (9%), total cholesterol (7%), and HDL-c (11%) (Larosa, Fry,
Muesing, & Rosing, 1980; Newbold, 1988; Phinney et al., 1983; Phinney et al., 1980;
Sharman et al., 2002; Volek, Gómez, & Kraemer, 2000). Finally, Krauss and coworkers
have identified cholesterol and lipid panel responses with respect to diet are also
significantly correlated with genetics, grouped as either pattern B or pattern A (Krauss,
2005). Individuals falling into the pattern B group are predisposed to smaller LDL-c
particle sizes and also respond more favorably to low-fat, higher-CHO diets. However,
this makes up less than 30% of the population. All other individuals fall into pattern A,
identified as individuals whom have larger, fluffier LDL-c particles and negatively
respond to low-fat, high-CHO diets by shifting from a pattern A to a pattern B phenotype
(D. Dreon, Fernstrom, Miller, & Krauss, 1994; D. M. Dreon, Fernstrom, Williams, &
Krauss, 1999; Krauss, 2005). To illustrate, over 70% of the population responds to a lowfat, high-CHO diet by increasing LDL-c particle number and decreasing particle size
which is a known risk for CVD and therefore, depicts how CRD can have beneficial
effects on cholesterol and lipid panels in both healthy populations and individuals with
metabolic syndrome.
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Glucose
Blood glucose is tightly regulated by human physiology and maintained at
adequate levels by glucocorticoid hormones to stay within a teaspoon range of
approximately four grams (100 mg/dL) at all times (Wasserman, 2009). However, a
characteristic of an individual with metabolic syndrome are fasted glucose levels which
exceed 100 - 110 mg/dL, also known as hyperglycemic, and is also a prevalent risk factor
for CHD (Ford, Giles, & Dietz, 2002). As detailed earlier, insulin directly regulates
glucose uptake into either muscle or adipose tissue. As seen in metabolic syndrome,
hyperglycemic conditions occur when the IRS becomes unresponsive to the insulin
substrate, resulting in unregulated glucose levels (Cefalu, 2001). Aside from
pharmacological interventions, CHO restriction is being considered as a prominent
method for improving glucose tolerance and insulin sensitivity.
Glucose tolerance and an individual’s risk for developing type II diabetes is
assessed via a standardized glucose challenge test (GCT) in which individuals consume a
50-75 g solution of glucose or dextrose and have blood sampled at baseline and again 1 h
later (Ooshima, 1987; Stumvoll et al., 2000). Well-controlled isocaloric diets, in which
meals were provided to healthy males and glucose responses assessed (but varying in
CHO load) showed that glucose production was reduced in a dose-response relationship
with a lower glycemic load (Bisschop et al., 2000). More chronic studies (> 3 weeks)
have shown similar findings in that CHO restriction resulted in a significant decrease of
plasma resting glucose values from 167 to 119 mg/dL (Gannon & Nuttall, 2004). The
evidence linking both glycemic load and index to the development of CVD (McKeown et
al., 2004), metabolic syndrome (Franz et al., 2002), and diabetes (Salmeron et al., 1997)
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is compelling. Volek and colleagues have attributed the improved glucose control to
enhanced translocation of GLUT-4 following CHO restriction. Specifically, GLUT-4
movement to the cell membrane is enhanced during exercise or during periods of low
CHO availability due to low muscle glycogen availability (Hespel & Richter, 1990).
Therefore, as long as glycogen levels remain low, the muscle cell is essentially readily
available for the uptake of glucose. Given the main source of calories for FF comes from
heavily processed and simple sugars (Haddock et al., 2015; Poston et al., 2013) and that
FF rank third in obesity prevalence among forty different male occupations (Caban et al.,
2005) as well as the shared relationship between obesity and impaired glucose intolerance
share (Ferrannini & Camastra, 1998), CRD have a potential role for repairing
dysfunctional GLUT-4 vesicles and improving overall systemic glucose sensitivity in FF.
C-Reactive Protein
C-reactive protein (CRP) is a marker of systemic inflammation produced by the
liver during times of physiological stress, and elevated levels are strongly correlated with
a risk of developing CVD (Prasad, 2003). When the allostatic load of cells have become
overwhelmed, these cells start to die as part of the apoptosis process (Pepys &
Hirschfield, 2003). Dying cells are then bound to CRP which are signaled by the acute
release of interleukin-6 (IL-6), an inflammatory cytokine produced by macrophages to
begin the process of phagocytosis (Pepys & Hirschfield, 2003). Further, while the
aforementioned markers (insulin and cortisol) are both excellent indicators of the risk for
developing CVD, CRP is considered the strongest independent predictor of CVD, even
compared to IL-6 and cholesterol levels (Danesh et al., 2004; Ridker, Hennekens, Buring,
& Rifai, 2000).
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With regard to specific macronutrient effects on CRP, the literature has shown
high consumption of trans fats or a large bolus of glucose/fructose to both directly
increase systemic inflammation through mediation of reactive oxygen species (ROS)
(Esposito et al., 2002; Lopez-Garcia et al., 2005; Mohanty et al., 2000). Moreover, there
is evidence suggesting high fat diets and red meat will significantly increase CRP (Arya
et al., 2006; Azadbakht & Esmaillzadeh, 2008; Montonen et al., 2013). However, these
same studies are extremely high in CHO as well, simulating a more westernized diet than
a primarily high fat diet and are mostly self-reported rather than calorically controlled.
Further, due to the enzymatic changes that occur within the mitochondria when CHO are
restricted, it is reasonable to assume an acute duration (< 3 weeks) of meals containing
higher amounts of fat and protein would place some level of stress on both the cell and
liver. Regardless of macronutrient distribution, the research is clear that when diets are
calorically controlled, CRP is mostly improved through a reduction in body weight,
preferably loss of fat mass, rather than diet macronutrient composition (Noakes et al.,
2006; Volek & Sharman, 2004). CHO restriction demonstrated effectiveness in both
dietary intervention for weight loss and outperforming similar isocaloric diets with
respect to a loss in fat mass, as detailed further below (Bravata et al., 2003; Brehm,
Seeley, Daniels, & D’alessio, 2003; Brinkworth et al., 2009). Therefore, while it is not
hypothesized that the macronutrient distribution found in CRD will directly influence
CRP levels, it is reasonable to presume the body composition changes found in CRD will
indirectly affect CRP values favorably.
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Body Composition
In simple terms, body composition is the relative percentage of body mass
composed of either fat mass or fat free mass (i.e. muscle). Body composition is a wellestablished predictor for an individual developing a host of serious adverse health events.
For example, the storage of excess adipose tissue around vital organs, known as android
fat, increases the risk for sudden heart infarction, CVD, atherosclerosis, cancer, even
more (Medicine, 2013). In males between the ages of 20 and 60 years old, elevated or
high body fat percentages are present at rates of 20-27% (American College of Medicine,
2013). In a 16-year follow up study, excess adipose tissue was consistently associated
with metabolic dysfunction, hypertension, and increased rates of all-cause mortality
(Zhang, Rexrode, Van Dam, Li, & Hu, 2008). While the effects of being overweight are
well understood as to circulatory, cardiovascular, and neuroregulatory systems, the
underlying cellular causes of adipose storage are related to an overabundance of nutrient
exposure to cells that contribute to ROS formation and increased rates of lipogenesis
which subsequently lead to the development of metabolic disorders (Sankhla et al.,
2012). It is this mechanism, the cell-nutrient exposure, which has made diets such as the
ketogenic diet and intermittent fasting popular caloric deficit interventions for current
researchers. However, both diets have been considered extreme approaches. Instead, a
successful diet treatment plan for weight loss must not only create a caloric deficit, but
also be a diet in which an individual can adhere.
An alternative dietary approach is one in which CHO are restricted, but not
necessarily in such a way that induces endogenous ketones. Low CHO diets (< 25% total
kcals) have been shown to be as effective, if not better, at inducing weight loss and
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improving metabolic variables than low-fat and low calorie diets (Bravata et al., 2003;
Brehm et al., 2003; Brinkworth et al., 2009; Yudkin & Carey, 1960). As detailed in
earlier sections, both protein and fat have high satiety ratings. When combined during
meals, it is the collectively higher satiation that results in caloric reduction and weight
loss. Dietary fat aside, previous research demonstrates that reductions in CHO leads to
protein ingestion naturally increasing (Waldman et al., 2017) thus promoting lean mass
retention during weight loss. Therefore, a researcher could make a strong argument that a
diet which induces weight loss primarily through adipose tissue and spares lean mass
creates a metabolic advantage not found in other diets. This hypothesis has been
demonstrated in the first systematic study on CHO restriction and body composition
changes where Benoit and team placed individuals on a hypocaloric CRD for 10 days and
reported an average body mass loss of 600 g/day, of which 97% was from fat mass
(Benoit, Martin, & Watten, 1965). Other investigations have demonstrated similar
findings. Young and colleagues took college aged males and placed them on three
different calorically matched diets differing in CHO content (30 g, 60 g, and 100 g). After
following the diets for nine weeks, subjects had body composition changes measured via
underwater weighing and found that weight loss for the three diets was 16.2 kg, 12.8 kg,
and 11.9 kg and fat mass accounted for 95%, 84%, and 75%, respectively (Young,
Scanlan, Im, & Lutwak, 1971). Further, adherence to a chronic CRD is generally higher
compared to low fat and low calorie diets (Brinkworth et al., 2009; Hu et al., 2016;
Krebs, Gao, Gralla, Collins, & Johnson, 2010; Nickols-Richardson, Coleman, Volpe, &
Hosig, 2005; Shai et al., 2008; Tay, Brinkworth, Noakes, Keogh, & Clifton, 2008; Volek,
Phinney, et al., 2009). Although satiety hormones will not be measured in the present
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study, some researchers have concluded adherence is greater in a CRD due to decreases
in the appetite stimulant ghrelin and without the constant calorie counting and portion
control is associated with many/the majority of other diets (McClernon, Yancy,
Eberstein, Atkins, & Westman, 2007; Nickols-Richardson et al., 2005).
Firefighter Performance
FF, by occupation, are required to maintain a higher level of cardiorespiratory
fitness and musculoskeletal strength. Duties that FF might face during a field exercise or
on-duty call include hose dragging, short distance (< 200-350 m) sprints, long distance (>
350 m) runs, victim carries, room clear procedures, ladder climbing; and all while
wearing personal protective equipment (PPE) which can weigh upwards of 35 kg
(Gavhed & Holmér, 1989) and while exposed to heat which can exceed 100° C, thus
exacerbating the metabolic demands required to complete a specific task (Dimri,
Malhotra, Gupta, Kumar, & Arora, 1980). Moreover, a higher thermal environment is
known to accelerate muscle glycogen depletion, potentially impairing performance
(Cheuvront, Kenefick, Montain, & Sawka, 2010). However, firefighting has been
proposed as predominately an aerobic occupation mixed with short bouts of anaerobic
tasks (Lemon & Hermiston, 1977; Perroni et al., 2010). When high-intensity tasks are
required, lactate levels have been recorded at upwards of 13.1 mmolL-1 (Lemon &
Hermiston, 1977), heart rates (HR) observed at between 80-100% of an individual’s
maximum (Gledhill & Jamnik, 1992), and energy requirements corresponding to 80% of
a FF V̇O2 max (Gledhill & Jamnik, 1992). Interestingly, body composition among FF is
known to impact performance in a number of ways. Excessive adipose tissue and
exposure to high thermal environments simultaneously, inhibits a FF ability to dissipate
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heat through sweat aside from adding dead weight during tasks such as ladder and stair
climbing (Williford, Duey, Olson, Howard, & Wang, 1999). Therefore, given FF
primarily perform in aerobic conditions and a large percent (70%) of FF have been
recorded as being overweight or obese (Wilkinson et al., 2014), a dietary intervention
which promotes weight-loss without performance hindrance, potentially improving lowintensity aerobic performance, would benefit FF and tactical personnel alike.
A plethora of evidence is available examining the role of CRD on performance
across a range of intensities. Although many of these interventions have used highly
trained elite athletes (Burke et al., 2002; Burke et al., 2017; Lambert et al., 2001;
Lambert, Speechly, Dennis, & Noakes, 1994), there are a handful of recent studies which
have looked at CHO restriction in healthy, moderately trained males that would closer
mimic present day FF. Specifically, one study found that when eight middle-aged (40 
10 years), recreational male runners (V̇O2 peak 49.2  4.2 mL·kg -1·min- 1 ) were placed
-

on a CRD for 3 weeks, fat oxidation rates significantly increased from pre-diet
intervention to post-diet, and participants lost on average 2.5 kg of body mass without
any decrements to running performance (Heatherly et al., 2017). This is consistent with
other recent studies which placed healthy, non-elite but trained participants on CRD for
3- and 4 weeks (Klement et al., 2013; Zajac et al., 2014). The findings were conclusive:
CRD for non-elite athletes will generally result in improved body composition, higher fat
oxidation rates at rest and during exercise, and no apparent performance decrements
(Klement et al., 2013; Zajac et al., 2014). These same findings have been shown in acute
and chronic higher intensity exercise investigations where performance capacity might be
hindered due to a reduction in glycogen stores while on a CRD. Arguably the most well
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controlled chronic CRD utilizing a resistance training program showed after eight weeks,
participants produced similar strength values and skeletal adaptations to those following a
higher CHO diet (J. M. Wilson et al., 2017). Further, this study not only showed that the
CRD did not hinder anaerobic performance, but CHO restriction resulted in a more
favorable testosterone range than those individuals following the WD.
With regard to performance, a common criticism of CRD are the short durations
for which they are implemented. Although enzymatic and cellular changes can occur
within 7 days of diet implementation (Carey et al., 2001; Goedecke et al., 1999), this
short duration can lead to performance detriments given the individuals lack of
accommodation time to the aforementioned adaptations. While 7 days does not seem to
be an appropriate time period for observing a nutrition interventions effects on
performance, Heathery et al. did find that positive performance responses to a low CHO
diet can be found within a 21-day time period (Heatherly et al., 2017).
Given the current evidence, a CRD could potentially benefit FF performance by
way of decreasing fat mass, but not affecting strength or aerobic performance negatively.
Positive and negative responders to a CRD should be found within a 28-day time period
as proposed by the present study.
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CHAPTER III
MATERIALS AND METHODS
Participants
Twenty-one apparently healthy, male professional FF were recruited from
surrounding local fire departments for the proposed investigation. Sample size estimation
was determined a priori, based on previous dietary interventions from our laboratory
(Heatherly et al., 2017; Waldman et al., 2017), as well as unpublished FF investigations
from our laboratory, and using G-Power software (Düsseldorf, Germany) which
determined 15 participants would be sufficient to achieve a desired power of 0.8, using a
moderate-high effect size, and an alpha level set at 0.05.
Selection Criteria
In brief, individuals were allowed to participate in the present study if they met
inclusion and exclusion criteria previously set by our laboratory in both unpublished and
published findings (Waldman et al., 2017). Inclusion criteria included: (1) participants
must be an active duty, male FF, (2) meet the American College of Sports Medicine lowrisk guidelines (Medicine, 2013), (3) obtain at least 150 min of moderate-intensity
aerobic activity or 60 min of vigorous intensity aerobic activity per week, (4) avoid
consumption of all dietary supplements that are not acceptable by the National College
Athletic Association for the duration of the study (steroids, multi-vitamins, thermogenics,
etc.), (5) refrain from caffeine and alcohol consumption 24 h prior to the experimental
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testing sessions, (6) “cleared for duty” after a yearly physical examination which all FF
must undergo, and (7) currently consuming ( 40% E) from CHO and have maintained
stable body mass for the previous two weeks before beginning the present study. Subjects
were excluded from the study if they were found to: (1) be currently taking anabolic
hormones that are not medically administered, (2) not adhering to the CRD on multiple
(3x) bouts when randomly selected for a dietary recall, and (3) be a current cigarette
smoker or prescribed cardiometabolic prescription drugs by a medical professional. Three
participants had to discontinue participation before beginning the CRD due to scheduling
conflicts, one participant dropped on request due to personal obligations, and two
participants were medically dropped due to serious injuries sustained from firefighting
during the 28-day intervention. Therefore, a total of 15 participants completed the study
(age = 33.5  9.7 yrs; height = 178.8  6.3 cm; mass = 89.1  12.7 kg; fire-service = 7.9
 7.4 yrs).
Experimental Design
In order to examine the given hypotheses, the current study implemented a
within-subject, repeated measures design with dependent variables analyzed at multiple
time points across the intervention. To best observe shifts in blood markers, body
composition, oxidation rates, and performance, participants reported to the laboratory on
nine separate occasions, three initial sessions to washout any potential order and learning
effect (Familiarization), three sessions 15-days later to establish a baseline (Baseline 1),
and another three sessions following the 28-day CRD (Post-CRD). An overview of the
study is shown in Figure 1.
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Experimental Procedures
The primary aim of the proposed study was to examine the effects of CHO
restriction on cardiometabolic parameters in FF. Secondary purposes for the study
included examining the effects of CHO restriction on body composition, oxidation rates,
and performance variables in FF. Preliminary data were collected upon the initial visit.
Participants completed an informed consent document approved by the University’s
Institutional Review Board, completed general health documents (i.e. health
questionnaire, physical activity readiness-questionnaire (PAR-Q), medical history
questionnaire), as well as provided a 3-day (e.g. Thursday, Friday, Saturday) dietary
recall. After inclusion and exclusion criterion were met, each participant was informed of
the purpose of the study and the following procedures required and expected of each
participant for the duration of the study.
Trials 1, 4, and 7
Blood Sampling and Glucose Challenge Test. Trial 1 took place 48 h after
preliminary data collection and occurred in the Joseph A. Chromiak Applied Physiology
Laboratory located in McCarthy Gymnasium following at least a 10-12 h fast, between
the hours of 0430 – 0900. Given that some of the blood markers follow a diurnal pattern,
participants arrived to all subsequent trials at the same time (30 min). All participants
were asked to refrain from strenuous exercise, not related to their occupation, 48 h before
reporting to the laboratory. Participants were also directed to come back to the laboratory
the following day if exposed to smoke 24 h before trial 1, 4, or 7 took place. Upon
arrival, participants had their body mass and height measured via a digital scale
(Defender 5000, Ohaus Corporation, Parsippany, NJ, USA) and digital stadiometer
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(235D; QuickMedical, Issaquah, WA, USA), respectively. Body composition (shown as
% fat) and resting metabolic rates (RMR) were analyzed via the BOD POD version 1.69
(Body Composition System; Life Measurement Instruments, Concord, CA).
Due to the lack of literature examining the loss of water and changes in lean body
mass across a range of body composition assessments, differences in subcutaneous fat
and lean muscle mass were further assessed using a seven-site skinfold technique as seen
in past CRD literature (Heatherly et al., 2017) and in agreement with Jackson and Pollock
ACSM skinfold measurement techniques (Medicine, 2013).
After skinfold measurements, individuals were asked to lie quietly in a supine
position and relax for at least 5 min on a table, due to acute blood plasma shifts (14%)
that might have occurred when moving from a standing to lying position (Harrison,
1985). Following this time and after applying proper sterilization techniques to the blood
draw site, a total of 12 mL of blood were drawn into two, 6 mL sodium heparin sealed
vacutainers from the antecubital vein via a 21 G, Safety-Lok butterfly needle (REF#
367287, Franklin Lakes, NJ). All sealed vacutainers were subsequently centrifuged at 4
ºC for 10 min at 2500 rpm and stored at -80º C following plasma removal for later
analysis.
After the initial antecubital blood draw, participants underwent a GCT and were
asked to consume a 400 mL bolus of water containing 75 g of a glucose mixture within a
5 min time period (NOW Sports, Dextrose Powder). Participants had their finger pricked
by a 26 gauge Dynarex (1.8 mm, Orangeburg, NY) self-withdrawing safety lancet, at
which point 5 microliters (μL) were analyzed for glucose (Precision Xtra, Abbott,
Alameda, CA) levels at time points 0, 30, and 60 min to determine risk for impaired
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fasting glucose and glucose tolerance levels as defined by the World Health Organization
(Alberti & Zimmet, 1998) and previous literature (Ooshima, 1987; Stumvoll et al., 2000).
During Trial 7, participants included the 75 g of CHO from the GCT towards their daily
allotted CHO amount. Following the GCT, all subjects were then directed to a chair
which provided back support and then asked to sit quietly for 20-25 min. The right arm
was then elevated to heart level and BP recorded (V100 Monitor, CarescapeTM, Fairfield,
CT) twice, with a 1-2 min time lapse between recordings. The two readings were then
averaged unless the difference was greater than 5 mm Hg at which point an additional
reading was made.
Insulin. Insulin was analyzed in thawed plasma using a commercially available
kit (Alpco, CAT# 80-INSHUU-E01.1, Salem, NH, USA). Insulin is a polypeptide
hormone secreted by the beta cells of the pancreatic islets and regulates the metabolism
of CHO, proteins, and fat. The ultrasensitive insulin ELISA utilizes a sandwich type
immunoassay with a functional sensitivity of 0.135 µlU/mL. Following reagent
preparation, 25 µL of samples, standards, and controls were added to their respective
wells which are coated with a monoclonal antibody specific for insulin and then followed
by adding 100 µL of anti-human insulin specific detection antibody. The plate was then
incubated for 60 min at room temperature (18-25º C), followed by a wash (6x) with the
prepared wash buffer. Tetramethylbenzidine (TMB) was then added followed by an
additional 30-min incubation period. One 100 µL of a stop solution was added to each
well and then read at a wavelength of 450 nm according to the company’s instructions.
Following absorbance measurements, the mean data value for each set of duplicated
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samples was plotted on a standard curve and subsequently analyzed using a 4-parameter
fit.
Cortisol. Cortisol was analyzed in duplicate samples from plasma using a
competitive immunoassay via a commercially available kit (Alpco, CAT# 11-CORHUE01, Salem, NH, USA). Cortisol is the major glucocorticoid secreted by the adrenal
cortex and when excessively elevated, can negatively affect cardiometabolic markers
(e.g. BP, blood glucose, cholesterol, etc.). After bringing all components of the ELISA kit
to room temperature, all samples, reagents, and controls were then added to their
respective wells where a competitive HRP-conjugate was added. The plate was then
incubated at 37º C for 1 h. A TMB substrate was then added which was catalyzed by
HRP causing a blue coloration. The TMB reaction was terminated by a stop solution,
then producing a yellow color and immediately read at an intensity of 450 nm with a
sensitivity of 2.44 ng/ml and optical density read via 4-parameter curve per assay
instructions.
C-Reactive Protein. Thawed plasma CRP levels were diluted 1:100 before
assaying in duplicated samples according to the ELISA kit instructions (Alpco, CAT# 309710s, Salem, NH, USA). Pilot data found that diluting plasma samples 1:100 resuled in
absorbance values consistent with standard absorbances (1.9 – 150 ng/mL). CRP is an
acute phase reactant and important marker of systemic and chronic low-grade
inflammation. The current assay is a sandwich immune-assay ELISA and uses a
polyclonal antibody to bind CRP during the first incubation step. Following the second
incubation step, a second polyclonal-labeled antibody is added followed by the addition
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of a stopping solution (TMB). The stopping solution produces a yellowish color which
absorbs light at 450 nm. Absorbance corresponds to the concentration of CRP and a 4parameter algorithm was used to calculate the results.
Lipid Panel. Following proper sterile cleaning procedures of the blood draw site,
participants had their finger pricked by a 26 gauge Dynarex (1.8 mm, Orangeburg, NY)
self-withdrawing safety lancet, at which point 5 μL were analyzed for a lipid panel (e.g.
total cholesterol (TC), LDL-c, HDL-c, TAG, TC/HDL-c) using a Cholestech LDX
System (Cholestech Corporation, Hayward, CA). The Cholestech LDX system utilizes a
‘color reaction’ step which allows for a reflectance reading to be collected for each lipid
marker and subsequently its conversion into quantitative values, also known as
reflectance photometry. The Cholestech LDX has been shown to be a valid tool for
examining the aforementioned lipid markers and are within the acceptable guidelines of
the National Cholesterol Education Program (Issa, Strunz, Giannini, Forti, & Diament,
1996).
Trials 2, 5, and 8
Graded Exercise and Wingate Testing. Trial 2 took place 48 h later and
consisted of a five stage, graded exercise test on a cycle ergometer using VelotronTM
Wingate software (RacerMate, Inc., Seattle, WA, USA). Participants arrived to the
laboratory and following at least a 10-12 h overnight fast, a HR H10, Polar Electro Inc.,
Lake Success, NY, USA) monitor was fixated across each participant’s chest and
cardiorespiratory measures collected using a MOXUS Modular V̇O2 system (AEI
technologies, Bastrop, TX, USA). The present graded exercise test was adopted from
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Achten and Jeukendrup (2003) as a valid protocol for measuring an individual’s substrate
oxidation rates and modified to start at a lighter intensity. Briefly, cycling began at 50 W
and work rate increased 35 W every 3 min until five stages had been completed.
Subjective measurements (i.e. rate of perceived exertion (RPE)) were obtained during the
last 30-s of each stage using a 10 point modified Borg scale (Borg, 1982).
Following completion of the graded exercise test, participants were asked to continue
cycling at 70 revolutions per min (RPM) and at a 100 W for a 4 min cool down period while
the researchers removed the MOXUS headgear. At the end of the cool down period,
participants were asked to complete a maximal, 30-s Wingate sprint at 0.075 kp • kg-1 body

mass of resistance which was added magnetically by the Velotron. Prior to the sprint,
participants were given a 7-s countdown to increase maximal cadence against a resistance
of 100 W.
Substrate Metabolism Calculations. All data collected from the MOXUS
Modular V̇O2 system was used to calculate substrate oxidation rates. V̇O2, respiratory
exchange ratio (RER), and carbon dioxide production (V̇CO2) were averaged from
steady-state expired gases. With regard to substrate oxidation, the first 120 s of each stage
were excluded and the remaining 60 s were recorded using breath by breath data and
averaged in two, 30 s cycles. Rates of both fat and CHO oxidation (g•min-1) were
calculated using Stoichiometric equations from the averaged V̇O2 and V̇CO2. The
present Stoichiometric equation assumes the oxidation of protein contributes minimally
to energy requirements (~5%) during the completion of the graded exercise test and
therefore, will be ignored during calculations (Brouwer, 1957).
Fat oxidation (g•min-1) = 1.718*V̇O2 – 1.718*V̇CO2
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CHO oxidation (g•min-1) = 4.170*V̇CO2 – 2.965*V̇O2

Trials 3, 6, and 9
Firefighter Physical Performance Assessment. Following Trial 2, Trial 3
consisted of participants performing their bi-annual FF physical performance assessment
(FPPA) which is a mandatory physical training test required by all active personnel FF in
the surrounding region. The FPPA consists of a 2.41-km timed run, immediately
followed by completion of as many repetitions as possible within 2 min for each exercise:
pull-ups, push-ups, and sit-ups, respectively. A 2.41-km loop outside the laboratory was
marked off and the three remaining exercises took place inside the laboratory.
Participants were asked to refrain from strenuous exercise, not related to their occupation,
24 h before arrival and to arrive in athletic attire. Upon arrival, participants performed a
general warm up which consisted of cycling at a 100 W for 2 min followed by 10
repetitions of pull-ups, push-ups, sit-ups, and air squats. After participants had a HR
monitor fixed across their chest, a timer was started followed by a “go” signal indicating
to the participant the FPPA had started. Upon completion of the 2.41-km run, the
participant immediately entered the weight-room located in the laboratory to finish the
three remaining exercises with no rest afforded between exercises. Completion of the
FPPA and number of repetitions for all three exercises were used as data points for preand post-diet intervention.
Dietary Manipulation. After the completion of Trial 6, participants then began
the diet intervention for a total of 28 days before reporting back to the laboratory for the
last three sessions. The present study utilized a CHO restricted, but caloric ad-libitum diet
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protocol seen in recent research (Heatherly et al., 2017). The primary purpose for the adlib design was due to the occupation of the participants. Due to fluctuations in physical
activity experienced by FF, implementation of a pre-determined caloric range undermines
the decreased or increased energy expenditure that FF can experience on any day or
during any time due to occupational demands. Moreover, given the role of adherence for
the success of any dietary protocol (Gardner et al., 2018), an ad-libitum diet allows for
flexibility into a participant’s lifestyle and mimics real-life eating patterns. Therefore,
during the first visit to the laboratory, participants were guided thoroughly on
implementing a CRD into their current lifestyle. Participants were provided with CHO
restricted sample daily menus, grocery lists with low CHO food items, and fast food
choices relevant to the local surrounding fast food chains that included low CHO options.
To further help with self-efficacy while on the diet, all participants were either met in
person by the principal investigator (PI) or participated in a FaceTime phone session that
took place at the local grocery store. During this session, participants were taught how to
interpret a food label as well as calculate absolute net CHO (CHO – fiber – sugar
alcohol). The session ended with the participants and PI combining food items from the
store to make actual low CHO meals and snacks each participant could implement into
their 28-day intervention. After providing the PI with their initial 3-day food log, the
participants average caloric intake was calculated and 25% of this number was then used
as their allotted CHO amount per day. All other macronutrients (e.g. fat and protein) were
allowed ad-libitum and participants were asked to track all foods and beverages daily in
MyFitnessPal (MyFitnessPal, Calorie Counter, 2018, Baltimore, MD). In an attempt to
maintain further adherence, participants were selected at random daily, using a random
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number generator, to retrieve and send a full day of food logs to the PI during the 28-day
intervention. Furthermore, all participants were asked to send a complete 2-day food log
consisting of a Friday and Saturday which was used to analyze and report weekly
macronutrient and caloric changes. All dietary food logs were subsequently analyzed for
caloric and macronutrient distribution using the food analysis software Nutrionist-Pro
(version 7.4, 2018, Axxya Systems-Nutrionist Pro, Stafford, TX. USA). Each night
messages were sent out by the PI to remind all participants to continue recording all
foods as well as tracking macronutrient compositions and this allowed for a daily
correspondence to be maintained between the participants and PI. Finally, the CRD
intervention was overseen by a Registered Dietician maintained within the University’s
nutrition department.
Physical Fitness Regimen. In an effort to control for training volume during the
diet intervention, both the fire-house station lieutenant and lead FF instructor collectively
developed a four day per week traditional bodybuilding training protocol (e.g. chest,
back, legs, arms and core). The training protocol manipulated repetitions, sets, and loads
from week to week, but overall, maintained a relatively constant total training volume
that did not differentiate more than ~100 kgs between each week. In addition, one aerobic
conditioning day (2.41-5.0 km) was mandated to be completed by all participants and one
field exercise (i.e. structure fire suppression, victim search and rescue, etc.) was
performed bi-monthly. Training was overseen by the station lieutenant who verbally
confirmed 13 participants met all training requirements, one participant completed ~50%
of the training requirements, and one participant (instructor) was unaccounted for given
his current training regimen to prepare for a national FF competition which he competes
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in bi-yearly. Further, both the station lieutenant and battalion chief confirmed the
aforementioned training regimen is regularly maintained among all FF, regardless of the
participants involvement with the present study.
Statistical Methods
Body composition (% body fat, fat free mass, total mass, and fat mass, RMR, and
seven-site skinfolds), blood concentrations of insulin, cortisol, CRP, TC, HDL-c, LDL-c,
non-HDL-c, TAG, TAG/HDL-c, and TC/HDL-c ratios, as well as blood pressure (SBP
and DBP), Wingate variables (fatigue index, mean watts, peak watts, total work, finishing
HR, relative mean watts, and relative peak watts), FPPA variables (2.41-km finishing
time, 2.41-km finishing HR, pull-ups, push-ups, and sit-ups), and diet variables (protein,
CHO, and fat) measured by g/kg, were all analyzed using a dependent t-test. Time points
0, 30, and 60 min during the GCT were analyzed using a 2 × 3 (Treatment [Baseline vs.
Post-CRD] × Time point) repeated measure analysis of variance (RMANOVA).
Cardiorespiratory variables (V̇E, HR, RER, V̇O2, V̇CO2, relative V̇O2, relative V̇CO2,
and RPE) and substrate oxidation rates for both fat and CHO (g•min-1) were analyzed
using a 2 × 5 (Treatment [Baseline vs. Post-CRD] × Time point [Stages 1, 2, 3, 4, and 5])

RMANOVA. All other diet variables were analyzed using a one-way (Time point)
ANOVA. If significant main effects or interaction effects were observed, Fisher’s Least
Significant Difference (LSD) post hoc tests were used to examine any further differences.
Partial eta square (ηp²: 0.01 = small effect; ηp²: 0.09 = moderate effect; ηp²: 0.25 = large
effect) and Cohen’s d (d: 0.2 = small, d: 0.5 = moderate, and d: 0.8 = large effect) were
calculated to provide effect sizes and are used to interpret meaningful differences (Cohen,
1988). Confidence intervals are reported as 95% CI [lower limit, upper limit] and used to
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interpret the value of the unknown population parameter. Statistical procedures were
conducted using SAS 9.4 (SAS Institute, Inc. 2011, Cary, North Carolina, USA).
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Figure 1.

Schematic of experimental protocol.

The figure represents the overall timeline of the 28-day dietary intervention. CHO =
Carbohydrate.
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CHAPTER IV
RESULTS
Anthropometrics
All data are reported as mean ± standard deviation (SD). Body composition
changes from pre to post diet are presented in Table 1. Body composition measurements
collected from the BodPod demonstrated a significant difference found in mean body
mass (t = 5.99, p = 0.001, d = 0.22, 95% CI [1.76, 3.71]). Overall, body mass
significantly decreased from 89.2 ± 12.6 to 86.5 ± 12.5 (kg) following the diet. A
significant decrease was found in fat mass (t = 6.44, p = 0.001, d = 0.35, 95% CI [1.62,
3.23]), but no significant differences were found for fat free mass (t = 0.01, p = 0.99, d =
0.00, 95% CI [-1.10, 1.09]). RMR significantly decreased following the diet (t = 2.25, p =
0.04, d = 0.10, 95% CI [1.11, 45.82]) as did total % body fat (t = 5.03, p = 0.001, d =
0.34, 95% CI [1.26, 3.14]). With regard to the seven-site skinfold measurements,
significant changes were found for the chest (t = 4,70, p = 0.001, d = 0.70, 95% CI [1.52,
4.08]), abdominals (t = 2.34, p = 0.03, d = 0.40, 95% CI [0.22, 5.11]), and thigh (t = 3.10,
p = 0.008, d = 0.30, 95% CI [0.32, 1.81]). No significant differences were found for the
axilla (t = 1.80, p = 0.09, d = 0.16, 95% CI [-0.14, 1.61]), triceps (t = 1.95, p = 0.07, d =
0.16, 95% CI [-0.12, 2.24]), subscapular (t = 0.63, p = 0.54, d = 0.09, 95% CI [-0.81,
1.47]), and suprailiac (t = 0.84, p = 0.42, d = 0.11, 95% CI [-0.84, 1.90]). Overall, a
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significant decrease was also found for % body fat as measured by skinfolds (t = 3.25, p
= 0.006, d = 0.37, 95% CI [-0.42, 2.05]).
Finally, a significant decrease was found in both SBP (t = 3.07, p = 0.008, d =
0.87, 95% CI [1.81, 10.19]) and DBP (t = 3.11, p = 0.007, d = 0.76, 95% CI [1.53, 8.33])
following the diet intervention.
Blood Concentrations
Changes in blood levels as measured by ELISA can be viewed in Figures 2, 3,
and 4, and changes in blood levels as measured by the Cholestech LDX can be viewed in
Table 1. In terms of plasma insulin, no significant differences were found from pre to
post-intervention (t = 1.54, p = 0.15, d = 0.44, 95% CI [-0.76, 4.67]) nor were significant
differences found for plasma cortisol (t = 0.63, p = 0.54, d = 0.16, 95% CI [-1.80, 3.28]).
However, a significant decrease was found for plasma CRP from pre to post diet (t =
2.16, p = 0.05, d = 0.30, 95% CI [0.00, 0.41]).
A significant increase was found for HDL-c (t = 2.50, p = 0.02, d = 0.34, 95% CI
[-8.06, -0.61]). No further significant differences were found for TC (t = 1.04, p = 0.32, d
= 0.25, 95% CI [-28.83, 10.03]), LDL-c (t = 1.72, p = 0.11, d = 0.19, 95% CI [-27.23,
3.08]), non-HDL (t = 0.70, p = 0.50, d = 0.18, 95% CI [-26.58, 13.52]), or TC/HDL-c (t =
0.74, p = 0.47, d = 0.11, 95% CI [-0.25, 0.52]). However, significance was approached
for decreases in both TAG (t = 1.83, p = 0.08, d = 0.64, 95% CI [-3.81, 47.41]) and
TAG/HDL-c (t = 1.99, p = 0.06, d = 0.59, 95% CI [-0.06, 1.52]).
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Wingate Testing
Mean Power Output
Following the diet intervention, absolute mean power output did not significantly
change (t = 1.07, p = 0.30, d = 0.10, 95% CI [-13.35, 40.15]). Regarding relative mean
power output, significant differences were not found pre- to post-treatment (t = 0.39, p =
0.70, d = 0.03, 95% CI [-0.36, 0.25]).
Peak Power Output
There were no significant differences following the diet for absolute peak power
(t = 0.43, p = 0.67, d = 0.06, 95% CI [-71.57, 107.60]). Moreover, relative peak power
output was not significantly different pre-to post-intervention (t = 0.62, p = 0.55, d =
0.08, 95% CI [-1.46, 0.80]).
Fatigue Index
Significant differences were not found for fatigue index following the diet
intervention (t = 0.44, p = 0.67, d = 0.09, 95% CI [-2.99, 4.53]).
Total Work
Total work completed pre- and post-diet were not significantly different from one
another (t = 0.08, p = 0.94, d = 0.01, 95% CI [-913.50, 982.60]).
Wingate Heart Rate
Significant differences were not found for HR (t = 0.46, p = 0.66, d = 0.09, 95%
CI [-2.97, 4.57]). Overall, finishing HR were similarly matched pre- and post-diet, 179 ±
9 bpm vs. 178 ± 12 bpm, respectively. All Wingate testing variables can be viewed in
Table 2.
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Firefighter Physical Performance Assessment
All FPPA variables pre- and post-diet intervention can be viewed in Figure 5. A
significant difference was observed from pre- to post-diet for the 2.41-km finishing run
time (t = 3.09, p = 0.008, d = 0.01, 95% CI [0.13, 0.70]). However, 2.41-km finishing HR
were not significantly different from one another (t = 0.00, p = 1.00, d = 0.00, 95% CI [3.06, 3.06]), thus suggesting that physical exertion was not significantly different across
both trials. Participants performed significantly more pull-ups post-CRD than at baseline
(t = 3.27, p = 0.005, d = 0.34, 95% CI [-4.09, -0.85]). However, no further significant
changes were found for either push-ups (t = 1.42, p = 0.18, d = 0.46, 95% CI [-16.25,
3.32]) or sit-ups (t = 0.83, p = 0.42, d = 0.20, 95% CI [-7.17, 3.17]).
Glucose Challenge Test
Blood glucose responses to the GCT pre and post diet intervention can be viewed
in Figure 6. With respect to the GCT, there was not a significant treatment × time point
interaction (F = 2.21, p = 0.12, ηp² = 0.06, 95% CI [0.00, 0.15]). Further, there were no
significant treatment effects found pre or post-CRD (F = 0.01, p = 0.93, ηp² = 0.00, 95%
CI [0.00, 0.21]). There was a significant difference found for time point (F = 97.26, p =
0.001, ηp² = 0.74, 95% CI [0.57, 0.76]). Overall, blood glucose responses were highest at
30 min. The 60 min time point remained significantly higher than minute 0, but
significantly lower than the 30 min period due to a fall in blood glucose levels following
the 30 min time point.
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Graded Exercise Testing
Substrate Oxidation Rates
Substrate oxidation rates for both fat and CHO (g•min-1) can be viewed in
Figure 7. With respect to fat oxidation, there was no treatment × time point interaction (F =

0.99, p = 0.42, ηp² = 0.03, 95% CI [0.00, 0.07]). However, significant main effects were
found for treatment (F = 7.22, p = 0.008, ηp² = 0.05, 95% CI [0.00, 0.13]) and for time
point (F = 25.39, p = 0.001, ηp² = 0.45, 95% CI [0.28, 0.50]). Overall, fat oxidation rates
significantly increased from baseline to post-CRD, 0.18 ± 0.19 vs. 0.24 ± 0.25 (g•min-1),
respectively. Further, time points 1-5 were all significantly different from each other, with fat
oxidation rates decreasing during each stage (p < 0.05).

With regards to CHO oxidation rates, there was no treatment × time point
interaction (F = 1.00, p = 0.41, ηp² = 0.03, 95% CI [0.00, 0.07]). However, significant

main effects were found for treatment (F = 11.76, p = 0.008, ηp² = 0.09, 95% CI [0.01,
0.16]) and for time point (F = 241.07, p = 0.001, ηp² = 0.88, 95% CI [0.83, 0.89]).
Overall, there was a significant decrease in CHO oxidation rates from baseline to the
post-CRD intervention, 2.15 ± 1.24 vs. 1.91 ± 1.19 (g•min-1), respectively. Further, time
points 1-5 were all significantly different from each other, with CHO oxidation rates
increasing during each stage (p < 0.05).

Cardiorespiratory Responses
With respect to HR, there was no treatment × time point interaction (F = 0.34, p =
0.89, ηp² = 0.01, 95% CI [0.00, 0.02]). There were however, significant main effects
found for both treatment (F = 4.60, p = 0.03, ηp² = 0.03, 95% CI [0.00, 0.09]) and time
points (F = 396.45, p = 0.001, ηp² = 0.93, 95% CI [0.89, 0.93]). Overall, HR was found to
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be significantly higher (+2 bpm) during the graded exercise test following the diet.
Further, time points 1-5 were all significantly different from each other, with HR increasing
during each stage (p < 0.01).

There was no treatment × time point interaction found for RPE (F = 1.00, p = 0.42,
ηp² = 0.03, 95% CI [0.00, 0.06]). There were however, significant main effects found for
both treatment (F = 5.47, p = 0.02, ηp² = 0.03, 95% CI [0.00, 0.09]) and time points (F =
210.86, p = 0.001, ηp² = 0.87, 95% CI [0.81, 0.88]). In brief, the differences found for
RPE regarding treatment showed that RPE was lower following the intervention than at
baseline (p < 0.05). Further, RPE increased across 1-5 time points and were all
significantly different from each other (p < 0.01).
With respect to relative V̇CO2, there was no treatment × time point interaction (F =
0.38, p = 0.82, ηp² = 0.01, 95% CI [0.00, 0.03]). Moreover, significant differences were
not found for main effect treatment (F = 0.38, p = 0.54, ηp² = 0.00, 95% CI [0.00, 0.04]),
but significant differences were found for main effect time point (F = 452.42, p = 0.001,
ηp² = 0.93, 95% CI [0.09, 0.93]). Overall, relative V̇CO2 increased across 1-5 time points
and were all significantly different from each other (p < 0.01). Regarding absolute V̇CO2,
no treatment × time point interaction (F = 0.41, p = 0.80, ηp² = 0.01, 95% CI [0.00, 0.04])
was found. However, significant main effects were found for treatment (F = 11.38, p =
0.001, ηp² = 0.08, 95% CI [0.01, 0.16]) and time point (F = 739.72, p = 0.001, ηp² = 0.96,
95% CI [0.94, 0.96]). Overall, baseline values of V̇CO2 were significantly higher than
after the diet intervention, 1.96 ± 0.67 vs. 1.88 ± 0.67 L/min, respectively. Further, V̇CO2
increased across 1-5 time points and were all significantly different from each other (p <
0.01).
58

With respect to relative V̇O2, there was no treatment × time point interaction (F =
2.01, p = 0.10, ηp² = 0.06, 95% CI [0.00, 0.11]). Moreover, significant differences were
not found for main effect treatment (F = 0.84, p = 0.35, ηp² = 0.01, 95% CI [0.00, 0.05]),
but significant differences were found for main effect time point (F = 557.78, p = 0.001,
ηp² = 0.95, 95% CI [0.92, 0.95]). Overall, relative V̇O2 increased across 1-5 time points
and were all significantly different from each other (p < 0.01). Regarding absolute V̇O2,
there was no treatment × time point interaction (F = 1.86, p = 0.12, ηp² = 0.06, 95% CI
[0.00, 0.10]). Moreover, significant differences were not found for main effect treatment
(F = 2.62, p = 0.11, ηp² = 0.02, 95% CI [0.00, 0.08]), but significant differences were
found for main effect time point (F = 784.90, p = 0.001, ηp² = 0.96, 95% CI [0.94, 0.96]).
Overall, absolute V̇O2 increased across 1-5 time points and were all significantly different
from each other (p < 0.01).
With respect to relative V̇E, there was no treatment × time point interaction (F =
0.41, p = 0.80, ηp² = 0.01, 95% CI [0.00, 0.03]). Moreover, significant differences were
not found for main effect treatment (F = 0.14, p = 0.71, ηp² = 0.00, 95% CI [0.00, 0.03]),
but significant differences were found for main effect time point (F = 297.06, p = 0.001,
ηp² = 0.90, 95% CI [0.85, 0.91]). Overall, V̇E increased across 1-5 time points and were
all significantly different from each other (p < 0.01).
With respect to relative RER, there was no treatment × time point interaction (F =
0.13, p = 0.97, ηp² = 0.00, 95% CI [0.00, 0.00]). However, significant differences were
found for main effect treatment (F = 24.11, p = 0.001, ηp² = 0.16, 95% CI [0.05, 0.24])
and time point (F = 102.18, p = 0.001, ηp² = 0.76, 95% CI [0.66, 0.78]). Overall, RER
values were significantly lower for post-CRD compared to baseline, 0.91 ± 0.09 vs. 0.95
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± 0.09, respectively. Further, RER increased across 1-5 time points and were all
significantly different from each other (p < 0.01).

Macronutrient Diet Breakdown
Kilocalories and Nutrients
All macronutrient changes during the study can be viewed in Table 3. With regard
to caloric intake, a significant main effect was not found for time point (F = 1.75, p =
0.15, ηp² = 0.11, 95% CI [0.00, 0.19]). Overall, kcals remained similarly matched across
the diet intervention. Regarding total consumption of sugar, a significant decrease was
found following the start of the diet (F = 10.00, p = 0.001, ηp² = 0.42, 95% CI [0.15,
0.48]). Overall, consumption of sugar at baseline was significantly higher (p < 0.01) than
at all other time points during the diet. With respect to fiber intake, a significant
difference was not found during the intervention (F = 1.17, p = 0.34, ηp² = 0.08, 95% CI
[0.00, 0.15]). Overall, fiber intake remained fairly constant from baseline to post-CRD.
Regarding cholesterol intake, a significant main effect for time point was not found (F =
1.59, p = 0.19, ηp² = 0.10, 95% CI [0.00, 0.18]). Overall, participants daily intake of
cholesterol was not significantly different from baseline to post-diet intervention. Finally,
a significant difference for saturated fat ingestion was not found across the diet
intervention (F = 0.47, p = 0.75, ηp² = 0.03, 95% CI [0.00, 0.07]).
Dietary Carbohydrate Intake
With regards to CHO intake, a significant main effect was found for both absolute
CHO intake (F = 50.55, p = 0.001, ηp² = 0.78, 95% CI [0.61, 0.80]) as well as percentage
60

of CHO intake (F = 45.11, p = 0.001, ηp² = 0.76, 95% CI [0.58, 0.78]). Further, relative
(g/kg) CHO intake significantly decreased following the diet (t = 8.20, p = 0.001, d =
2.11, 95% CI [1.32, 2.25]).
Dietary Protein Intake
A significant main effect was found for both absolute protein intake (F = 7.51, p =
0.001, ηp² = 0.35, 95% CI [0.10, 0.42]) as well as percentage of protein intake (F = 18.41,
p = 0.001, ηp² = 0.57, 95% CI [0.31, 0.61]). However, relative (g/kg) protein intake was
not significantly different following the diet (t = 1.92, p = 0.07, d = 0.65, 95% CI [-0.67,
0.04]).
Dietary Fat Intake
A significant main effect was not found for absolute fat intake (F = 0.67, p = 0.61,
ηp² = 0.05, 95% CI [0.00, 0.10]), however, the percentage of fat intake did significantly
increase post-CRD (F = 8.46, p = 0.001, ηp² = 0.38, 95% CI [0.12, 0.45]). Further,
relative (g/kg) fat intake was not significantly different following the diet (t = 0.60, p =
0.56, d = 0.20, 95% CI [-0.57, 0.32]).
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Plasma Insulin
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Figure 2.

Post-CRD

Insulin.

Individual plasma insulin responses for the 28-day CRD. The bold lines represent
individual improvements in resting insulin measurements. The dashed lines represent
individuals that failed to match or improve resting insulin measurements following the
diet intervention. The bold line with the larger marker ends represents mean values.
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Plasma Cortisol
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Figure 3.

Post-CRD

Cortisol.

Individual plasma cortisol responses for the 28-day CRD. The bold lines represent
individual improvements in resting cortisol measurements. The dashed lines represent
individuals that failed to match or improve resting cortisol measurements following the
diet intervention. The bold line with the larger marker ends represents mean values.
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Plasma C-Reactive Protein
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Figure 4.

Post-CRD

C-Reactive protein.

Individual plasma CRP responses for the 28-day CRD. The bold lines represent
individual improvements in resting CRP measurements. The dashed lines represent
individuals that failed to match or improve resting CRP measurements following the diet
intervention. The bold line with the larger marker ends represents mean values.
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Firefighter physical performance assessment.

Results show changes (mean ± SD) for FPPA performance variables in the order they
were completed, pre- and post-CRD. (A). Each bar represents mean time (min) to
completion (± SD) during the 2.41-km time trial run; Average HR for each trial is shown
in its respective bar. (B). Completed number of pull-ups. (C). Completed number of
push-ups. (D). Completed number of sit-ups. *Significant change found pre- to post-CRD
(p < 0.05).
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Figure 6.

Glucose challenge test.

Responses show blood glucose responses (mean ± SD) at time points 0, 30, and 60 min
following ingestion of a 75 g glucose. *Indicates significance (p < 0.05) between time
points, but not treatments.

66

Figure 7.

Substrate oxidation rates.

Results show relationships (mean ± SD) between substrate utilization (A: CHO oxidation
rates; B: Fat oxidation rates) and exercise power output in FF across a 28 day CRD
intervention.
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Table 1
Body Composition and Lipid Responses
Baseline
89.2 ± 12.8
19.6 ± 6.3
17.8 ± 7.0
71.6 ± 9.3
1916.1 ± 248.5

Post-CRD
86.5 ± 12.5‡
17.4 ± 6.5‡
15.3 ± 6.8‡
71.6 ± 9.2
1892.7 ± 236.9

Body mass (kg)
BodPod Fat (%)
BodPod Fat (kg)
BodPod Lean Mass (kg)
Resting Metabolic Rate
Skinfold thickness (mm)
Chest
12.6 ± 3.7
8.9 ± 3.6‡
Midaxillary
10.9 ± 4.3
10.2 ± 4.8*
Tricep
9.6 ± 3.4
8.5 ± 3.0*
Subscapularis
13.3 ± 2.9
12.9 ± 4.4
Abdominal
19.7 ± 6.5
17.1 ± 7.0†
Suprailliac
10.6 ± 3.9
10.1 ± 4.9
Thigh
12.1 ± 3.6
11.1 ± 3.5‡
Sum
87.7 ± 24.8
78.8 ± 26.9‡
Skinfold BF (%)
13.4 ± 3.2
12.2 ± 3.5‡
Systolic BP (mm Hg)
124.0 ± 8.0
118.0 ± 6.0‡
Diastolic BP (mm Hg)
76.0 ± 6.0
70.0 ± 6.0
Total Cholesterol (mg/dL)
167.0 ± 27.3
176.0 ± 44.9
HDL-c (mg/dL)
46.0 ± 12.7
51.0 ± 15.5†
Non-HDL-c (mg/dL)
119.0 ± 30.0
126.0 ± 40.4
LDL-c (mg/dL)
99.0 ± 29.0
108.0 ± 40.1
Triacylglycerols (mg/dL)
92.0 ± 45.5
70.0 ± 15.2*
Triacylglycerols/HDL-c (mg/dL)
2.3 ± 1.6
1.6 ± 0.7*
Total Cholesterol/HDL-c
3.9 ± 1.3
3.7 ± 1.1
Responses shown are following 4 weeks of carbohydrate-restricted diet (CRD) versus
habitual baseline diet (n = 15; mean ± SD).
† = p < 0.05
‡ = p < 0.01
* = approached significance (p < 0.10).
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Table 2
Wingate Testing
Variable

Baseline

Post-CRD

Peak Power (watts)
1264.5  301.9
1246.4  333.0
Mean Power (watts)
719.3  127.9
705.9  149.9
Total Work (joules)
21579.3  384.8
21545.4  4620.3
Fatigue Index (watts/second)
27.6  7.9
26.9  8.2
Relative Mean Power (watts/kg)
8.1  1.3
8.1  1.4
Relative Peak Power (watts/kg)
14.2  2.9
14.5  4.0
Max Heart Rate (bpm)
179.0  9.0
178.0  12.0
Data are presented as mean  SD. Wingate testing results are reported for pre-and postdiet intervention.
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Table 3
Macronutrient Composition Breakdown
28-days Carbohydrate Restricted Diet
Day-7
Day-14
Day-21
1696 ± 677
1877 ± 766
1813 ± 877

Diet Variable
K/cals

Baseline
2090 ± 770

Post-CRD
1650 ± 911

Protein (E%)
Protein (g)
Protein (g/kg)

32 ± 6
133 ± 48

31 ± 6
144 ± 59

30 ± 8
130 ± 52

29 ± 7
114 ± 52
1.3 ± 0.5

CHO (E%)
CHO (g)
CHO (g/kg)

18 ± 7†
88 ± 34†
0.9 ±
0.4***
47 ± 8*
244 ± 98*
2.7 ± 1.1**

20 ± 8
76 ± 31

18 ± 11
77 ± 32

23 ± 10
95 ± 36

23 ± 11
84 ± 34
0.9 ± 0.3

Fat (E%)
Fat (g)
Fat (g/kg)

35 ± 7†
85 ± 40
0.9 ± 0.4 ‡

48 ± 10
96 ± 53

51 ± 9
110 ± 56

47 ± 11
102 ± 74

48 ± 11
95 ± 75
1.0 ± 0.7

Saturated Fat (g)

30 ± 10

32 ± 21

38 ± 23

35 ± 27

33 ± 27

Cholesterol (mg)

323 ± 233

294 ± 232

229 ± 222

182 ± 169

180 ± 127

Sugar (g)

87 ± 70*

29 ± 23

30 ± 28

32 ± 19

29 ± 16

Fiber (g)
14 ± 7
17 ± 11
18 ± 18
14 ± 10
12 ± 8
Results shown are diet variables across the entire intervention. (n = 15; mean ± SD).
*Indicates significantly greater than days 7-28 (p < 0.05).
**Indicates significantly greater than Post-CRD (p < 0.05).
***Approached significance (p < 0.10).
‡Indicates significantly lower than Post-CRD (p < 0.05).
†Indicates significantly lower than days 7-28 (p < 0.05).
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CHAPTER V
DISCUSSION
The purpose of this investigation was to examine the metabolic and performance
effects of a 28-day CRD in male FF. Overall, the results from this study suggest 4 weeks
of a CRD can mitigate markers of CVD as evidenced by significant improvements to
HDL-c, body composition, blood pressure, and reductions in CRP. Further, these
metabolic improvements were accompanied by significantly faster 2.41-km run times and
an increase in pull-up repetitions although no changes were found in push-ups, sit-ups, or
Wingate variables. Current data are mixed with regards to the performance effects of
CHO restriction with some studies demonstrating improvements to performance
(Goedecke et al., 1999; Heatherly et al., 2017; Klement et al., 2013; Lambert et al., 1994;
Paoli et al., 2012; Wilson et al., 2017), no changes at all (Pitsiladis & Maughan, 1999),
and other studies showing performance detriments (Burke et al., 2017). However, this
study demonstrates that when following a CRD for 4 weeks, performance either
improved (e.g. 2.41-km time trial and pull-ups) or had no negative effects other than a
slight but significant increase in HR (+2 bpm) during the graded exercise test. Other
positive adaptations found during the investigation include significant reductions in RER,
RPE, CHO oxidation, and increases in fat oxidation.
The primary aim of the present study was to examine the cardiometabolic effects
of a CRD using the AHA guidelines for heart disease risk stratification (Go et al., 2014).
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To date, it is now accepted that LDL-c can no longer be considered a sole indicator of
heart disease risk nor even be considered a strong indicator for the development of heart
disease without also the consideration of cholesterol particle size, density, and count
(Holmes et al., 2018; St-Pierre et al., 2001). Evidence has emerged in the past 10 years
with studies demonstrating markers of CRP (Rudolf & Lewandrowski, 2014), HDL-c
(Briel et al., 2009), TC/HDL-c (Arsenault et al., 2009), and/or TAG/HDL-c (Luz,
Favarato, Faria-Neto Junior, Lemos, & Chagas, 2008) as being stronger indicators for
developing CVD. Moreover, the AHA has declared reductions to CRP and increases in
HDL-c can be considered the two strongest predictors of the development of heart
disease when examined collectively (Pearson et al., 2003; Ridker, 2003). In achieving the
aforementioned cardiometabolic improvements, leading organizations such as the AHA
and National Heart, Lung, and Blood Institute have made nutrition recommendations
with emphasis on reducing dietary fat and cholesterol (DeSalvo et al., 2016; Larosa et al.,
1990). However, this study is unique in that it used the same heart disease risk guidelines
put forth by the AHA, but an opposite approach with regards to nutrition instead
emphasizing a reduction in total CHO intake. Collectively, our findings show that a CRD
with high intakes of dietary fats can improve markers for heart disease as evidenced by
significant increases in HDL-c (+4.4 mg/dL; p = 0.02) and significant decreases in CRP
levels (-0.2 mg/L; p = 0.05). Although significant differences were not found with respect
to TC/HDL-c, TAG/HDL-c, non-HDL-c, or TAG, our CVD markers that were different
were strengthened by the significant reductions observed in both SBP (-6.0 mm Hg; p =
0.008) and DBP (-5.0 mm Hg; p = 0.007). These changes in BP are in agreement with
previous studies which found weight reductions of 2-4 kg also resulted in decreases of
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almost 5 mm Hg in both SBP and DBP (Semlitsch et al., 2016; Siebenhofer et al., 2016).
Data from observational studies show increases of 10 mm Hg in SBP or 5 mm Hg in
DBP can result in an increase of 20-25% higher rate of death stemming from CHD within
a 10 year span (MacMahon et al., 1990). As a group, the FF in this study were able to
change their BP category from elevated to normal (124.0 vs. 118.0 mm Hg) according to
the updated guidelines published in 2017 by the AHA (Whelton et al., 2018).
FF are documented as being one of the most overweight male occupations in
America with higher mortality rates from CVD than from firefighting (Kales & Smith,
2014; Walker SC Poston et al., 2011). Also well documented is the increased risk for onthe-job injuries in the fire service when an individual has an elevated BMI ( >25 kg/m2)
(Jahnke, Poston, Haddock, & Jitnarin, 2013; Walker SC Poston et al., 2011; Schmidt &
Mckune, 2012). A high BMI is also associated with higher BP and presents an even
greater risk when the accumulation of adipose tissue is around the abdominal region
known as android fat (Britton et al., 2013). Our data demonstrated that a 28-day CRD
significantly reduced fat mass (~2.4 kg), specifically around the abdominal region (~2.7
mm), while also maintaining lean mass. This is an interesting finding given that total
caloric intake (2091 ± 770 vs. 1759 ± 808 kcals) was not significantly different during the
study and all nutrients were ad-libitum within the allotted CHO amount. Previous
research has shown that FF over consume a majority of their calories from high-sugar,
low-nutrient sources (Haddock et al., 2015). This study’s participants significantly
reduced sugar consumption (~39%; 82 vs. 32 g; p = 0.001) and arguably reduced their
daily intake of low nutrient dense foods and beverages. This data currently point towards
CHO restriction as an effective nutrition intervention optimizing body composition
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without requiring a significant caloric deficit. The maintenance of lean mass was
attributed to the increase in absolute protein intake during the diet intervention (88 vs.
130 g). Although relative protein (g/kg) did not reach statistical significance (p = 0.07),
the increase from 0.9 to 1.3 g/kg put our participants in the lower range of dietary
recommendations for maintaining lean mass while losing fat (Demling & DeSanti, 2000;
Layman, 2004). Additionally, a thorough review demonstrated there exists an inverse
relationship between protein intake and BP (Elliott, 2003).
Another unique finding following this study was the lack of increase in either TC
or LDL-c. Although few studies have examined the biochemical changes that occur when
following a CRD, those which have generally show a slight-to-moderate rise in both
LDL-c and TC (Klement et al., 2013; Zajac et al., 2014). It is possible however, the rise
in different cholesterols associated with CRD are in regard to a KD, which requires lower
intakes of protein and CHO as well as higher intakes of fat. Although the current study
utilized a CRD, the parameters were not so extreme as to be considered a KD as such
stringent parameters on macronutrients are not applicable or realistic for high-stress
occupations such as FF. Regardless, this study suggests that individuals who suffer with
components of metabolic syndrome can achieve favorable cardiometabolic adaptations
with slight decreases in CHO intake, as illustrated in Tables 1 and 3. These data are
further strengthened by a previous study which showed that modest reductions in CHO
(~10%) across a 3-day period can alter nearly 400 FFA transcriptional genes, including
SREBP-1c and reduce overall TAG circulation (Sparks et al., 2006). This study’s
participants reduced overall CHO intake by an average of (~21%) and reduced TAG
appearance which approached significance (p = 0.08). Recent evidence has demonstrated
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TAG levels are generally a stronger predictor for the development of CVD than are levels
of LDL-c due to the relationship TAG levels share with low-grade inflammation, low
levels of HDL-c, and elevated CRP values (Singh & Singh, 2016). While molecular data
were not collected during the present study, based on our findings which show significant
decreases in CRP, significant increases in HDL-c, and near significant reductions in
circulating levels of TAG (Figure 4; Table 1); it is appropriate to speculate a 28-day CRD
had similar effects on SREBP-1c as Sparks et al. found (Sparks et al., 2006)
Further hypotheses made by the research team such as improvements in insulin,
cortisol, and glucose tolerance were not supported (Figures 2, 3, and 6). However, the
sample of FF studied were already deemed normal according to these three resting
markers and did not accurately reflect what the FEMA study suggested about FF as a
population (i.e. insulin resistant) (Superko et al., 2011). However, previous research has
shown even healthy males following a CRD can show modest reductions in already
normal levels of resting insulin values (3.8 to 1.7 ng/mL) within a 5-day period
(Waldman et al., 2017). The population tested in this study also had healthy levels of
insulin and therefore, findings would most likely be different for FF who are overweight
or with impaired glucose tolerance. It is also possible the lack of changes specifically to
insulin were not observed due to the duration of the current study which examined
changes after 28-days rather than every 5-days for 15-days as observed in (Waldman et
al., 2017). Although only speculation, insulin might have decreased early during the diet
(< 10-days) and risen again to normal, baseline levels by day 28.
We further hypothesized that following a CRD would improve metabolic
flexibility in our participants as measured by oxidation rates and cardiorespiratory
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markers via graded exercise test on a cycle ergometer. Dr. San-Millán and Dr. Brooks
recently proposed and conducted an innovative research strategy for the indirect
assessment of metabolic flexibility in individuals by measuring lactate and oxidations
rates during a similar cycling exercise test. (San-Millán & Brooks, 2017). Briefly,
metabolic flexibility is a term used to describe a healthy individual’s capacity to adapt to
fuel oxidation in response to nutrient availability (Storlien, Oakes, & Kelley, 2004).
Being in a state of metabolic inflexibility has been linked to insulin resistance (J. E.
Galgani, Moro, & Ravussin, 2008), heart disease (Taegtmeyer, Golfman, Sharma,
Razeghi, & Van Arsdall, 2004), and obesity (Battaglia, Zheng, Hickner, & Houmard,
2012). Variables which demonstrate metabolic inflexibility are high resting CHO
oxidation rates (~1.5 g•min-1), high resting blood lactate levels (~2 mmol•L-1), and low
resting fat oxidation rates (~0.2 g•min-1) (San-Millán & Brooks, 2017). Exercise is
known to improve the cell’s capability to utilize different substrates, as endurance
athletes are well regarded for having increased lactate clearance (Bergman et al., 1999)
and lipid oxidation rates (Bergman, Butterfield, Wolfel, Casazza, et al., 1999), decreased
reliance on CHO as a fuel source (Bergman, Butterfield, Wolfel, Lopaschuk, et al., 1999),
and much more robust mitochondrial reticulums (Jacobs & Lundby, 2012; Maruszak et
al., 2014; Nogales-Gadea et al., 2011). CHO restriction and caloric deficit diets have also
been shown to improve some of the mentioned markers in endurance trained males
(Heatherly et al., 2017), resistance trained males (Waldman et al., 2017), and obese
individuals (J. Galgani & Ravussin, 2009).
This study demonstrated that following a 28-day CRD can improve symptoms of
metabolic inflexibility as seen in significant reductions in post-intervention CHO
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oxidation rates (~0.24 g•min-1; p = 0.008), RER values (~0.04; p = 0.001) and significant
increases in post-intervention fat oxidation rates (~0.07 g•min-1; p = 0.008). Although
baseline lactate levels were not collected as performed by San-Millán and Brooks, these
data collectively demonstrated these participants were able to effectively shift fuel
selection from primarily a glucose dependent system at rest (resting CHO oxidation rates
pre to post-diet; 0.7 vs 0.6 g•min-1) to greater reliance on FFA after following the diet.
Lactate has been shown to decrease fat oxidation rates by inhibition of lipolysis through
the GPR81 receptor (San-Millán & Brooks, 2017). While lactate was not addressed in the
present study, an inverse relationship exists between fat oxidation and lactate levels (Liu
et al., 2009) and thus, it is reasonable to assume lactate levels would also have been
handled more efficiently as a mitochondrial substrate and equated to lower resting values
post-intervention. Lower blood lactate values as well as greater dependence on fat for
energy both at rest and during exercise would then explain the significant decrease in
resting V̇CO2 values (~0.12 L/min-1; p = 0.03), as well as overall significant reductions in
exercising V̇CO2 (1.96 vs. 1.88 L/min-1; p = 0.001) values during the graded cycling test
following the diet intervention. These data are backed by studies which have
demonstrated lower V̇CO2 when lipids are the primary oxidized fuel source as opposed to
glucose (Efthimiou et al., 1992; Kuo, Shiao, & Lee, 1993; Talpers, Romberger, Bunce, &
Pingleton, 1992). A unique finding to this study is the absent rise related to either
absolute or relative V̇O2 (p > 0.05) commonly used as a criticism for the reduced
exercise economy when following a CRD (Burke et al., 2017). Research shows that per
molecule, glucose produces a higher oxidative phosphorylation yield than does a FFA
due to the greater ratio of reducing equivalents NADH/FADH2 during CHO metabolism
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as opposed to ß-oxidation and overall, a higher ATP yield per O2 molecule consumed
(Leverve, Batandier, & Fontaine, 2007). Subsequently, when individuals become fat
adapted, oxygen consumption and total work output generally increase. Although from a
biochemistry viewpoint these claims are correct (Krogh & Lindhard, 1920), these
statements have also led to criticism, as the only time being fat adapted has negatively
impacted performance or shown indifferences has been in elite endurance trained athletes
(Burke et al., 2000; Burke et al., 2017; Carey et al., 2001; Goedecke et al., 1999; Vogt et
al., 2003). For athletes nearing maximal capacity of arterial oxygen extraction, a shift
from CHO towards fat oxidation may in fact limit performance and impair exercise
economy. Similar to the argument Heatherly et al., the participants in this study were
non-elite, middle-age male FF with arguably a higher relative ceiling for oxygen
extraction and any potential increases in V̇O2 during exercise would most likely be offset
by significant decreases in body mass (Heatherly et al., 2017). Even so, the graded
exercise test took place on a cycle ergometer which negated any changes in body mass
and still, absolute V̇O2 values remained unchanged. While only speculation, it is possible
the changes in absolute V̇O2 and much higher fat oxidation rates observed in previous
studies are due to the incorporation of a KD such as in the FASTER study (Volek et al.,
2016), when compared to fat oxidation rates observed in the current investigation (1.2 vs.
0.2 g•min-1, respectively). The present study was intent on implementing a non-KD CRD
and merely restricting CHO to only ~25%. KD generally require intakes of CHO under
~10% and this would not have been realistic for our participants. Therefore, it’s plausible
the CHO intake of our participants was low enough to contribute to a significant shift in
fat oxidation rates, but not so severe CHO oxidation was impaired; additionally oxygen
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consumption subsequently increased to compensate as V̇E was not significantly different
between treatments.
A small but significant (+2 bpm; p = 0.03) increase was found during the graded
exercise test post-CRD for HR. Research is clear that the sympathetic nervous system is
influenced by CHO availability (Helge, Richter, & Kiens, 1996; Lima-Silva et al., 2010;
McAllister et al., 2016; Penev, Spiegel, Marcinkowski, & Van Cauter, 2005; Sasaki,
Hotta, & Ishiko, 1991) and a past study has shown similar increases in HR during an
exercise cycling bout due to elevated plasma catecholamine levels following an
isocaloric, 7 week CRD (Helge et al., 1996). Therefore, it is reasonable to speculate the
increased HR in the present study was also due to higher plasma catecholamine levels
following our cycling exercise test, though these were not directly measured. While
critics of low CHO diets might find an elevated HR a negative outcome, it is important to
point out a small, but also significant decrease (2.2 vs. 2.0; p = 0.02) was found in overall
RPE following the diet, suggesting a reduced perceived effort while cycling. Although
both variables reached statistical significance, their implications for cardiometabolic and
performance benefits are small and should not be weighed heavily in interpreting the
benefits of a 28-day CRD.
Secondary aims of the present investigation were to examine the performance
effects of a CRD in male FF. FF are often tasked with duties that require high levels of
strength and cardiorespiratory fitness, such as victim carries, ladder climbs, floor crawls
(20-40 m), long and short distance sprints or runs, and all while wearing heavy (~20-35
kg) PPE (Gavhed & Holmér, 1989). High temperatures (+100° C) further intensify the
cardiometabolic demands required of FF and increase the rate of glycogen depletion as
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observed by Cheuvront et al. (2010). Previous low CHO diet investigations have shown
significant reductions in glycolytic enzymes (e.g. pyruvate dehydrogenase) and CHO
metabolism during high-intensity cycling bouts (Stellingwerff et al., 2006). It is
reasonable to assume a CRD which impairs CHO metabolism could potentially be
detrimental to FF performance. However, it should be re-stated that impairments to
performance are usually seen in studies utilizing either a KD or elite endurance trained
athletes. The present FF were following a resistance training program (~4x wk) over the
course of the intervention and 90% of the FF adhered to the training protocol. Further, FF
are required both by the National Firefighter Protection Association (N. F. P. Association,
2017) and their training officer to accumulate 60 min of training each day with strength
and aerobic work. Given the FF average of number of years (7.9 ± 7.4 yrs) spent in the
fire-service, then in agreement with National Strength and Conditioning Association
standards, these FF meet the intermediate resistance trained classification (Haff &
Triplett, 2015). With regard to resistance training and performance, the data favors a low
CHO diet as being more advantageous for a resistance-trained population, compared to
an endurance trained group (Gregory, Hamdan, Torisky, & Akers, 2017; Kephart et al.,
2018; Paoli et al., 2012; Waldman et al., 2017; J. M. Wilson et al., 2017). The results
from this study suggest 4 weeks of a CRD did not significantly impact measurements
(e.g. fatigue index, mean power, peak power, relative mean and peak power, HR, and
total work; p > 0.05) of a 30-s high-intensity cycling bout. There were however,
significant improvements observed during the FPPA. Specifically, FF improved both
2.41-km run time and pull-up repetitions (see Figure 5). There were no further
differences observed in either push-ups or sit-ups and no performance decrements found
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during the FPPA. While the investigators are aware that the FPPA might not exactly
replicate the physical requirements a FF can experience during a field training or on-duty
call, it is currently the standard used bi-yearly across the nation to determine if a FF is fit
for duty. It was for this reason the FPPA was chosen as a pre- and post-intervention
testing variable and deemed appropriate to utilize in examining how a CRD might impact
the physical readiness of a FF. Given these participants maintained their normal training
routine, performance was not hypothesized to improve since this study was merely a diet
intervention. Although this hypothesis was supported by the results of all Wingate
variables, the FPPA was significantly impacted, most likely due to the relative
bodyweight requirements of each task (i.e. running and calisthenics). Examining the data
would suggest loss of fat mass (~2.4 kg) while maintaining muscle mass had the greatest
impact on our performance variables and can be attributed to the higher protein intake
occurring when following a CRD. As seen in past studies (Waldman et al., 2017), when
CHO are restricted, protein naturally increases to make up for the caloric deficit and is
arguably the most important macronutrient for creating an optimal body composition
(Campbell et al., 2007).
Some limitations were present during the investigation that should be addressed.
As with all dietary interventions relying on self-reported data, each meal that our
participants consumed could not be monitored. The data we received were assumed to be
valid as participants were asked to record everything consumed in MyFitnessPal.
However, as is the case with high-stress, on-call and 24 h shift occupations, it is possible
forced impromptu meals, snacks, or drinks went unreported. An attempt to limit any
possible discrepancies as much as possible by requesting food logs at random throughout
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the week. Further, our team asked for weekly food logs from all participants including
both a weekday and weekend daywere requested. A second limitation could be if the FF
participated in additional training regimens outside of what was required of them. While
all participants verbally agreed they had followed the training program provided by the
training officer and no further exercise had occurred, additional training sessions would
have skewed body composition and performance variables. However, attempts to control
and limit this were made by designing a within, crossover study which should have
washed out any influencers or outliers if this did occur. On-duty calls could not be
controlled. While the battalion chief voiced the 28-days during the intervention was a
similar month with regards to on-duty calls as previous months, this still remains a
limitation. In an effort to minimize this, participants were asked before training sessions
if they had performed rigorous exercise in the past 48 h or if they had been exposed to
smoke in the past 24 h and if so, participants were asked to come back the following day
for testing.
While this study reflects limitations found in other dietary interventions, a
strength to this investigation is both its duration (28-days) and number of participants (n
= 15). A common criticism to CRD is the short duration (< 21-days) for which they are
conducted. Although metabolic changes can be found in as short as five days (Goedecke
et al., 1999), it is also understood these same adaptations impair performance acutely.
Heatherly et al. found responders to a CRD can be identified within 21-days (Heatherly et
al., 2017) and Aragon et al. suggested diets less than 28-days would most likely not
provide adequate time for performance adaptions to occur to any specific diet (Aragon et
al., 2017). Our participants followed the diet for 28-days before reporting back to the
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laboratory for the final three sessions. Moreover, studies investigating diet interventions
generally only finish with 5 -11 participants (Heatherly et al., 2017; Langfort, Zarzeczny,
Pilis, Nazar, & Kaciuba-Uścitko, 1997; Phinney, Bistrian, Evans, Gervino, & Blackburn,
1983; Phinney et al., 1983; Waldman et al., 2017). This study started with 21 and finished
with 15 participants. Finally, to date this is only the second investigation to implement a
diet intervention with FF and the first to use a CRD.
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CHAPTER VI
CONCLUSION
The primary purpose of the current investigation was to examine changes in
cardiometabolic markers and perform a risk assessment in a high-stress occupation when
following a CRD for 28-days. The secondary study purpose was related to performance
responses when following a low CHO diet. Collectively, our results suggest that a 28-day
CRD (1) significantly decreases markers of CVD and improves HDL-c, 2) significantly
improves favorable body composition changes (specifically fat mass), and 3)
significantly improves FF performance on their bi-annual FPPA.
Overall, current nutrition guidelines provided by organizations such as the AHA
encourage individuals struggling with weight and heart disease to reduce cholesterol and
fat intake and place emphasis on more CHO sources (i.e. fruit, vegetables, whole grains,
wheat, etc.). Our data suggests markers of heart disease can be significantly reduced and
performance maintained in high-stress occupations such as FF when following a CRD.
Researchers can use our intervention as a model for future nutrition studies aimed at
implementing dietary changes in similar populations. Futures studies should examine the
importance of personalized nutrition and other dietary protocols (i.e. intermittent fasting,
time-restricted eating, cyclic ketogenic dieting) for mitigating metabolic disease,
inflammation, and oxidative stress in high-stress occupations.
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